track name="Histone (@ BHY) 100" url="http://chip-atlas.org/view?id=$$" gffTags="on"
chr1 1624216 1624475 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 218 . 1624216 1624475 0,222,255
chr1 6259048 6259481 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 157 . 6259048 6259481 0,160,255
chr1 11072518 11072985 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 172 . 11072518 11072985 0,175,255
chr1 16840689 16841099 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 544 . 16840689 16841099 44,255,0
chr1 16970877 16971231 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 207 . 16970877 16971231 0,211,255
chr1 16993390 16993787 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 615 . 16993390 16993787 117,255,0
chr1 17066691 17067080 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 784 . 17066691 17067080 255,220,0
chr1 17222212 17222515 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 403 . 17222212 17222515 0,255,98
chr1 17231421 17231724 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 452 . 17231421 17231724 0,255,48
chr1 22109795 22110105 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 282 . 22109795 22110105 0,255,222
chr1 24018445 24018704 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 172 . 24018445 24018704 0,175,255
chr1 24151637 24151893 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 209 . 24151637 24151893 0,213,255
chr1 32110200 32110456 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 183 . 32110200 32110456 0,186,255
chr1 32688089 32688397 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 186 . 32688089 32688397 0,189,255
chr1 33116209 33116465 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 33116209 33116465 0,197,255
chr1 33502117 33502373 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 33502117 33502373 0,173,255
chr1 41157456 41157747 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 202 . 41157456 41157747 0,206,255
chr1 44412293 44412570 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 215 . 44412293 44412570 0,219,255
chr1 46215883 46216218 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 211 . 46215883 46216218 0,215,255
chr1 52831240 52831736 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 211 . 52831240 52831736 0,215,255
chr1 53163637 53163914 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 178 . 53163637 53163914 0,181,255
chr1 59165367 59165684 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 235 . 59165367 59165684 0,239,255
chr1 62190471 62190781 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 266 . 62190471 62190781 0,255,238
chr1 67390150 67390406 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 169 . 67390150 67390406 0,172,255
chr1 88335072 88335353 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 230 . 88335072 88335353 0,234,255
chr1 89149212 89149540 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 89149212 89149540 0,199,255
chr1 89150047 89150429 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 210 . 89150047 89150429 0,214,255
chr1 89239545 89239870 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 258 . 89239545 89239870 0,255,246
chr1 89240344 89240930 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 350 . 89240344 89240930 0,255,153
chr1 89356888 89357210 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 378 . 89356888 89357210 0,255,124
chr1 89457953 89458291 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 319 . 89457953 89458291 0,255,184
chr1 89488103 89488501 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 219 . 89488103 89488501 0,223,255
chr1 89530626 89530946 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 232 . 89530626 89530946 0,236,255
chr1 89989790 89990226 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 298 . 89989790 89990226 0,255,206
chr1 90309107 90309641 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 222 . 90309107 90309641 0,226,255
chr1 90460710 90461372 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 339 . 90460710 90461372 0,255,164
chr1 91487268 91487694 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 661 . 91487268 91487694 164,255,0
chr1 91966107 91966967 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 380 . 91966107 91966967 0,255,122
chr1 92764071 92764922 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 479 . 92764071 92764922 0,255,21
chr1 93049681 93050011 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 255 . 93049681 93050011 0,255,249
chr1 93270677 93271016 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 214 . 93270677 93271016 0,218,255
chr1 93297678 93298495 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 589 . 93297678 93298495 90,255,0
chr1 93373970 93374246 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 239 . 93373970 93374246 0,243,255
chr1 93427421 93427689 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 156 . 93427421 93427689 0,159,255
chr1 93544833 93545269 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 305 . 93544833 93545269 0,255,198
chr1 93645309 93645896 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 220 . 93645309 93645896 0,224,255
chr1 93646286 93646646 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 297 . 93646286 93646646 0,255,207
chr1 93810890 93811266 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 295 . 93810890 93811266 0,255,209
chr1 94159253 94159883 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 241 . 94159253 94159883 0,245,255
chr1 94166747 94167272 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 262 . 94166747 94167272 0,255,242
chr1 94204338 94204693 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 173 . 94204338 94204693 0,176,255
chr1 94245781 94246111 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 248 . 94245781 94246111 0,252,255
chr1 94344267 94344746 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 449 . 94344267 94344746 0,255,52
chr1 94344870 94345126 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 210 . 94344870 94345126 0,214,255
chr1 95007791 95008093 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 210 . 95007791 95008093 0,214,255
chr1 95045122 95045412 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 233 . 95045122 95045412 0,237,255
chr1 95071669 95072066 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 209 . 95071669 95072066 0,213,255
chr1 95087593 95088113 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 162 . 95087593 95088113 0,165,255
chr1 95088653 95089167 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 325 . 95088653 95089167 0,255,178
chr1 95179694 95179982 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 187 . 95179694 95179982 0,190,255
chr1 95200668 95201133 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 234 . 95200668 95201133 0,238,255
chr1 95257702 95257969 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 192 . 95257702 95257969 0,195,255
chr1 95328669 95329559 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 339 . 95328669 95329559 0,255,164
chr1 95392072 95392516 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 202 . 95392072 95392516 0,206,255
chr1 95634680 95635087 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 159 . 95634680 95635087 0,162,255
chr1 97187346 97187919 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 401 . 97187346 97187919 0,255,100
chr1 97743754 97744020 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 218 . 97743754 97744020 0,222,255
chr1 98518981 98519759 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 253 . 98518981 98519759 0,255,251
chr1 100315712 100315995 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 200 . 100315712 100315995 0,204,255
chr1 100503170 100503442 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 202 . 100503170 100503442 0,206,255
chr1 100503711 100504109 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 362 . 100503711 100504109 0,255,140
chr1 100598074 100598441 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 140 . 100598074 100598441 0,142,255
chr1 100714917 100715342 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 282 . 100714917 100715342 0,255,222
chr1 100731890 100732170 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 157 . 100731890 100732170 0,160,255
chr1 101360546 101361203 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 259 . 101360546 101361203 0,255,245
chr1 101361745 101362204 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 514 . 101361745 101362204 14,255,0
chr1 101491421 101491878 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 368 . 101491421 101491878 0,255,134
chr1 101615917 101616247 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 219 . 101615917 101616247 0,223,255
chr1 104068321 104068970 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 274 . 104068321 104068970 0,255,230
chr1 107599323 107599676 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 182 . 107599323 107599676 0,185,255
chr1 113161653 113162076 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 160 . 113161653 113162076 0,163,255
chr1 113162546 113162810 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 217 . 113162546 113162810 0,221,255
chr1 119682995 119683251 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 223 . 119682995 119683251 0,227,255
chr1 121484410 121485523 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 1000 . 121484410 121485523 255,0,0
chr1 144907855 144908117 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 136 . 144907855 144908117 0,138,255
chr1 145092099 145092355 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 137 . 145092099 145092355 0,139,255
chr1 145209527 145209783 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 158 . 145209527 145209783 0,161,255
chr1 145969400 145969712 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 351 . 145969400 145969712 0,255,151
chr1 146556292 146556578 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 271 . 146556292 146556578 0,255,233
chr1 147511139 147511466 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 359 . 147511139 147511466 0,255,143
chr1 147735492 147735772 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 317 . 147735492 147735772 0,255,186
chr1 147806887 147807161 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 331 . 147806887 147807161 0,255,172
chr1 147931167 147931443 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 202 . 147931167 147931443 0,206,255
chr1 150534215 150534503 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 150534215 150534503 0,173,255
chr1 151254023 151254341 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 203 . 151254023 151254341 0,207,255
chr1 153963281 153963589 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 201 . 153963281 153963589 0,205,255
chr1 154192675 154192994 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 200 . 154192675 154192994 0,204,255
chr1 159894775 159895036 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 150 . 159894775 159895036 0,153,255
chr1 160231844 160232130 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 189 . 160231844 160232130 0,192,255
chr1 161123711 161123971 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 161123711 161123971 0,197,255
chr1 203765384 203765643 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 155 . 203765384 203765643 0,158,255
chr1 203830893 203831195 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 180 . 203830893 203831195 0,183,255
chr1 204485574 204485874 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 218 . 204485574 204485874 0,222,255
chr1 205512916 205513172 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 205512916 205513172 0,173,255
chr1 225965710 225965993 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 181 . 225965710 225965993 0,184,255
chr1 228328068 228328344 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 200 . 228328068 228328344 0,204,255
chr1 235133465 235133859 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 143 . 235133465 235133859 0,145,255
chr1 235291803 235292090 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 157 . 235291803 235292090 0,160,255
chr1 243264643 243264970 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 261 . 243264643 243264970 0,255,243
chr1 245027140 245027587 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 163 . 245027140 245027587 0,166,255
chr10 1034481 1034770 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 178 . 1034481 1034770 0,181,255
chr10 4767916 4768193 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 216 . 4767916 4768193 0,220,255
chr10 14880433 14880689 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 14880433 14880689 0,199,255
chr10 27443674 27443988 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 181 . 27443674 27443988 0,184,255
chr10 32635659 32635999 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 274 . 32635659 32635999 0,255,230
chr10 42529301 42529635 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 231 . 42529301 42529635 0,235,255
chr10 43277733 43277990 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 163 . 43277733 43277990 0,166,255
chr10 43278258 43278517 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 172 . 43278258 43278517 0,175,255
chr10 51565288 51565664 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 276 . 51565288 51565664 0,255,228
chr10 53459440 53459731 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 208 . 53459440 53459731 0,212,255
chr10 60145261 60145583 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 60145261 60145583 0,202,255
chr10 60932871 60933142 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 152 . 60932871 60933142 0,155,255
chr10 64893166 64893422 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 197 . 64893166 64893422 0,200,255
chr10 69834659 69834971 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 273 . 69834659 69834971 0,255,231
chr10 70091977 70092555 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 214 . 70091977 70092555 0,218,255
chr10 70231350 70231648 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 158 . 70231350 70231648 0,161,255
chr10 70481062 70481589 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 173 . 70481062 70481589 0,176,255
chr10 70660473 70660857 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 245 . 70660473 70660857 0,249,255
chr10 70661069 70661359 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 225 . 70661069 70661359 0,229,255
chr10 70715970 70716418 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 376 . 70715970 70716418 0,255,126
chr10 70884225 70884508 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 203 . 70884225 70884508 0,207,255
chr10 70939764 70940313 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 210 . 70939764 70940313 0,214,255
chr10 73610586 73610947 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 207 . 73610586 73610947 0,211,255
chr10 74057312 74057641 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 230 . 74057312 74057641 0,234,255
chr10 75255126 75255471 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 204 . 75255126 75255471 0,208,255
chr10 75489947 75490228 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 208 . 75489947 75490228 0,212,255
chr10 75503477 75504008 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 211 . 75503477 75504008 0,215,255
chr10 75910492 75910793 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 342 . 75910492 75910793 0,255,161
chr10 78112515 78112827 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 182 . 78112515 78112827 0,185,255
chr10 89577602 89577893 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 210 . 89577602 89577893 0,214,255
chr10 93169471 93169814 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 176 . 93169471 93169814 0,179,255
chr10 93412728 93413052 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 192 . 93412728 93413052 0,195,255
chr10 97849664 97849946 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 222 . 97849664 97849946 0,226,255
chr10 97889780 97890277 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 280 . 97889780 97890277 0,255,224
chr10 98346089 98346363 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 177 . 98346089 98346363 0,180,255
chr10 99160652 99160939 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 99160652 99160939 0,174,255
chr10 99496987 99497333 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 153 . 99496987 99497333 0,156,255
chr10 99894451 99894852 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 99894451 99894852 0,202,255
chr10 102820120 102820731 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 197 . 102820120 102820731 0,200,255
chr10 103454409 103454681 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 103454409 103454681 0,174,255
chr10 103892872 103893347 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 232 . 103892872 103893347 0,236,255
chr10 103912268 103912631 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 209 . 103912268 103912631 0,213,255
chr10 105631506 105631791 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 105631506 105631791 0,173,255
chr10 105991704 105992040 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 284 . 105991704 105992040 0,255,220
chr10 112327224 112327534 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 160 . 112327224 112327534 0,163,255
chr10 115614205 115614632 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 149 . 115614205 115614632 0,151,255
chr10 116698049 116698313 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 197 . 116698049 116698313 0,200,255
chr10 120514004 120514260 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 162 . 120514004 120514260 0,165,255
chr10 120839776 120840245 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 212 . 120839776 120840245 0,216,255
chr10 124913950 124914210 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 293 . 124913950 124914210 0,255,211
chr10 127511858 127512127 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 183 . 127511858 127512127 0,186,255
chr10 134260757 134261388 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 169 . 134260757 134261388 0,172,255
chr10 135121795 135122201 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 246 . 135121795 135122201 0,250,255
chr11 236577 236842 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 246 . 236577 236842 0,250,255
chr11 236985 237334 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 189 . 236985 237334 0,192,255
chr11 355575 356023 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 274 . 355575 356023 0,255,230
chr11 394745 395065 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 229 . 394745 395065 0,233,255
chr11 506091 506770 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 426 . 506091 506770 0,255,75
chr11 576156 576453 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 436 . 576156 576453 0,255,65
chr11 695293 695613 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 346 . 695293 695613 0,255,157
chr11 809102 809875 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 227 . 809102 809875 0,231,255
chr11 1968629 1969170 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 430 . 1968629 1969170 0,255,71
chr11 3818304 3818738 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 207 . 3818304 3818738 0,211,255
chr11 4115508 4115793 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 158 . 4115508 4115793 0,161,255
chr11 6502148 6502488 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 181 . 6502148 6502488 0,184,255
chr11 6502869 6503226 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 163 . 6502869 6503226 0,166,255
chr11 6704125 6704458 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 6704125 6704458 0,202,255
chr11 8703853 8704136 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 273 . 8703853 8704136 0,255,231
chr11 8704427 8704953 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 243 . 8704427 8704953 0,247,255
chr11 8985968 8986324 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 179 . 8985968 8986324 0,182,255
chr11 9385169 9385744 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 271 . 9385169 9385744 0,255,233
chr11 9406245 9406911 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 291 . 9406245 9406911 0,255,213
chr11 9481720 9482154 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 429 . 9481720 9482154 0,255,72
chr11 9635044 9635330 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 148 . 9635044 9635330 0,150,255
chr11 9780003 9780330 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 268 . 9780003 9780330 0,255,236
chr11 9780626 9781105 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 255 . 9780626 9781105 0,255,249
chr11 9921374 9921655 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 180 . 9921374 9921655 0,183,255
chr11 10510262 10510612 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 10510262 10510612 0,199,255
chr11 10562357 10562618 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 198 . 10562357 10562618 0,201,255
chr11 10829706 10829968 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 173 . 10829706 10829968 0,176,255
chr11 12189104 12189360 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 172 . 12189104 12189360 0,175,255
chr11 12715582 12715946 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 204 . 12715582 12715946 0,208,255
chr11 13010649 13010905 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 169 . 13010649 13010905 0,172,255
chr11 13094647 13095035 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 192 . 13094647 13095035 0,195,255
chr11 13237133 13237499 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 13237133 13237499 0,197,255
chr11 13282586 13283159 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 237 . 13282586 13283159 0,241,255
chr11 14541436 14541820 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 239 . 14541436 14541820 0,243,255
chr11 17098792 17099138 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 401 . 17098792 17099138 0,255,100
chr11 17297748 17298026 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 167 . 17297748 17298026 0,170,255
chr11 18343820 18344120 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 191 . 18343820 18344120 0,194,255
chr11 18416302 18416623 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 144 . 18416302 18416623 0,146,255
chr11 18548143 18548866 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 301 . 18548143 18548866 0,255,202
chr11 19138835 19139091 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 141 . 19138835 19139091 0,143,255
chr11 19701304 19701695 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 181 . 19701304 19701695 0,184,255
chr11 19733732 19733996 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 135 . 19733732 19733996 0,137,255
chr11 20409375 20409758 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 145 . 20409375 20409758 0,147,255
chr11 27528016 27528272 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 172 . 27528016 27528272 0,175,255
chr11 30344709 30345134 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 180 . 30344709 30345134 0,183,255
chr11 32913829 32914101 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 204 . 32913829 32914101 0,208,255
chr11 33060886 33061219 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 251 . 33060886 33061219 0,255,253
chr11 33182488 33182973 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 383 . 33182488 33182973 0,255,119
chr11 33279034 33279548 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 256 . 33279034 33279548 0,255,248
chr11 34074493 34074793 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 172 . 34074493 34074793 0,175,255
chr11 34127316 34127572 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 34127316 34127572 0,173,255
chr11 34642711 34643415 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 244 . 34642711 34643415 0,248,255
chr11 34937334 34937680 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 149 . 34937334 34937680 0,151,255
chr11 35589715 35590035 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 146 . 35589715 35590035 0,148,255
chr11 36531542 36531836 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 176 . 36531542 36531836 0,179,255
chr11 43380513 43380913 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 43380513 43380913 0,197,255
chr11 43702374 43702776 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 320 . 43702374 43702776 0,255,183
chr11 45167786 45168215 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 308 . 45167786 45168215 0,255,195
chr11 46638807 46639481 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 237 . 46638807 46639481 0,241,255
chr11 47197888 47198367 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 184 . 47197888 47198367 0,187,255
chr11 47430288 47430674 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 279 . 47430288 47430674 0,255,225
chr11 47447294 47448030 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 393 . 47447294 47448030 0,255,109
chr11 47574068 47574434 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 165 . 47574068 47574434 0,168,255
chr11 47600269 47600551 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 234 . 47600269 47600551 0,238,255
chr11 47663592 47664018 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 252 . 47663592 47664018 0,255,252
chr11 47789277 47789679 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 257 . 47789277 47789679 0,255,247
chr11 57434930 57435237 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 370 . 57434930 57435237 0,255,132
chr11 57480114 57480410 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 213 . 57480114 57480410 0,217,255
chr11 57508995 57509543 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 221 . 57508995 57509543 0,225,255
chr11 57529393 57529872 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 159 . 57529393 57529872 0,162,255
chr11 58346000 58346256 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 246 . 58346000 58346256 0,250,255
chr11 59312494 59312866 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 309 . 59312494 59312866 0,255,194
chr11 59473829 59474314 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 181 . 59473829 59474314 0,184,255
chr11 61159927 61160364 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 211 . 61159927 61160364 0,215,255
chr11 61197031 61197343 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 217 . 61197031 61197343 0,221,255
chr11 61559779 61560720 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 288 . 61559779 61560720 0,255,216
chr11 61793401 61793667 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 191 . 61793401 61793667 0,194,255
chr11 61891533 61891800 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 155 . 61891533 61891800 0,158,255
chr11 62340893 62341187 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 152 . 62340893 62341187 0,155,255
chr11 62368353 62369121 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 183 . 62368353 62369121 0,186,255
chr11 62413600 62413984 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 275 . 62413600 62413984 0,255,229
chr11 62599224 62599530 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 262 . 62599224 62599530 0,255,242
chr11 62609214 62609703 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 380 . 62609214 62609703 0,255,122
chr11 62622920 62623273 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 219 . 62622920 62623273 0,223,255
chr11 62648487 62648921 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 206 . 62648487 62648921 0,210,255
chr11 62649352 62649609 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 190 . 62649352 62649609 0,193,255
chr11 63705715 63706011 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 262 . 63705715 63706011 0,255,242
chr11 63742118 63742532 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 317 . 63742118 63742532 0,255,186
chr11 64008069 64008413 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 367 . 64008069 64008413 0,255,135
chr11 64013499 64013947 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 200 . 64013499 64013947 0,204,255
chr11 64052386 64052692 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 205 . 64052386 64052692 0,209,255
chr11 64092538 64092813 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 205 . 64092538 64092813 0,209,255
chr11 64684213 64684567 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 258 . 64684213 64684567 0,255,246
chr11 64774045 64774322 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 168 . 64774045 64774322 0,171,255
chr11 64775029 64775392 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 176 . 64775029 64775392 0,179,255
chr11 64781215 64781521 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 200 . 64781215 64781521 0,204,255
chr11 64851095 64851499 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 252 . 64851095 64851499 0,255,252
chr11 64901964 64902486 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 417 . 64901964 64902486 0,255,84
chr11 65029490 65029876 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 142 . 65029490 65029876 0,144,255
chr11 65244479 65244909 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 234 . 65244479 65244909 0,238,255
chr11 65381361 65381668 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 226 . 65381361 65381668 0,230,255
chr11 65430761 65431017 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 147 . 65430761 65431017 0,149,255
chr11 65479545 65479970 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 413 . 65479545 65479970 0,255,88
chr11 65547752 65548079 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 294 . 65547752 65548079 0,255,210
chr11 65667193 65667502 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 206 . 65667193 65667502 0,210,255
chr11 66206000 66206432 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 217 . 66206000 66206432 0,221,255
chr11 66610492 66610769 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 245 . 66610492 66610769 0,249,255
chr11 67007651 67007938 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 185 . 67007651 67007938 0,188,255
chr11 67120673 67120929 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 141 . 67120673 67120929 0,143,255
chr11 67374448 67374779 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 246 . 67374448 67374779 0,250,255
chr11 67889159 67889513 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 221 . 67889159 67889513 0,225,255
chr11 68038977 68039295 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 168 . 68038977 68039295 0,171,255
chr11 68670908 68671205 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 175 . 68670908 68671205 0,178,255
chr11 68816565 68816821 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 162 . 68816565 68816821 0,165,255
chr11 69489478 69490189 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 485 . 69489478 69490189 0,255,15
chr11 69794437 69794698 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 221 . 69794437 69794698 0,225,255
chr11 69794861 69795529 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 558 . 69794861 69795529 59,255,0
chr11 69862637 69862956 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 155 . 69862637 69862956 0,158,255
chr11 69909408 69909679 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 168 . 69909408 69909679 0,171,255
chr11 69909998 69910529 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 309 . 69909998 69910529 0,255,194
chr11 70049434 70049832 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 314 . 70049434 70049832 0,255,189
chr11 70050165 70050763 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 323 . 70050165 70050763 0,255,180
chr11 70244180 70244474 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 190 . 70244180 70244474 0,193,255
chr11 70963160 70963416 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 70963160 70963416 0,174,255
chr11 71009827 71010363 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 331 . 71009827 71010363 0,255,172
chr11 71010777 71011041 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 185 . 71010777 71011041 0,188,255
chr11 71159743 71160190 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 247 . 71159743 71160190 0,251,255
chr11 71164343 71164714 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 337 . 71164343 71164714 0,255,166
chr11 71498624 71499216 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 267 . 71498624 71499216 0,255,237
chr11 71639172 71639794 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 437 . 71639172 71639794 0,255,64
chr11 71791995 71792330 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 245 . 71791995 71792330 0,249,255
chr11 71813698 71814256 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 249 . 71813698 71814256 0,253,255
chr11 71823510 71823877 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 353 . 71823510 71823877 0,255,149
chr11 72145320 72145576 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 240 . 72145320 72145576 0,244,255
chr11 72281557 72281855 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 136 . 72281557 72281855 0,138,255
chr11 72525068 72525373 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 335 . 72525068 72525373 0,255,168
chr11 73000334 73000626 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 209 . 73000334 73000626 0,213,255
chr11 73087785 73088189 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 209 . 73087785 73088189 0,213,255
chr11 73587250 73587816 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 270 . 73587250 73587816 0,255,234
chr11 74303653 74304240 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 410 . 74303653 74304240 0,255,91
chr11 74660388 74660723 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 251 . 74660388 74660723 0,255,253
chr11 75110669 75111293 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 271 . 75110669 75111293 0,255,233
chr11 75273345 75273639 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 201 . 75273345 75273639 0,205,255
chr11 75479422 75479783 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 356 . 75479422 75479783 0,255,146
chr11 75945744 75946071 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 264 . 75945744 75946071 0,255,240
chr11 75977731 75977987 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 75977731 75977987 0,197,255
chr11 76155278 76155704 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 334 . 76155278 76155704 0,255,169
chr11 76287966 76288255 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 243 . 76287966 76288255 0,247,255
chr11 76494505 76494827 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 281 . 76494505 76494827 0,255,223
chr11 76495087 76495572 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 240 . 76495087 76495572 0,244,255
chr11 76536478 76536803 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 191 . 76536478 76536803 0,194,255
chr11 76571999 76572323 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 338 . 76571999 76572323 0,255,165
chr11 76595877 76596223 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 201 . 76595877 76596223 0,205,255
chr11 76902836 76903134 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 240 . 76902836 76903134 0,244,255
chr11 76961524 76961904 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 234 . 76961524 76961904 0,238,255
chr11 77184173 77184495 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 180 . 77184173 77184495 0,183,255
chr11 77348392 77348795 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 350 . 77348392 77348795 0,255,153
chr11 77348891 77349162 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 177 . 77348891 77349162 0,180,255
chr11 77531261 77531710 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 381 . 77531261 77531710 0,255,121
chr11 77705162 77705655 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 256 . 77705162 77705655 0,255,248
chr11 77751188 77751720 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 447 . 77751188 77751720 0,255,54
chr11 77790433 77791257 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 360 . 77790433 77791257 0,255,142
chr11 77850158 77850684 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 407 . 77850158 77850684 0,255,94
chr11 82783201 82783457 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 176 . 82783201 82783457 0,179,255
chr11 82868311 82869118 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 198 . 82868311 82869118 0,201,255
chr11 85955680 85955996 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 253 . 85955680 85955996 0,255,251
chr11 86013313 86013745 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 210 . 86013313 86013745 0,214,255
chr11 93394955 93395260 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 93394955 93395260 0,197,255
chr11 93474250 93474513 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 161 . 93474250 93474513 0,164,255
chr11 93762141 93762452 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 238 . 93762141 93762452 0,242,255
chr11 96040591 96040848 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 149 . 96040591 96040848 0,151,255
chr11 105948474 105948788 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 256 . 105948474 105948788 0,255,248
chr11 107879701 107879981 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 210 . 107879701 107879981 0,214,255
chr11 108092961 108093251 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 227 . 108092961 108093251 0,231,255
chr11 108337842 108338144 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 282 . 108337842 108338144 0,255,222
chr11 116643294 116643683 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 216 . 116643294 116643683 0,220,255
chr11 118443153 118443409 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 276 . 118443153 118443409 0,255,228
chr11 118661261 118661532 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 180 . 118661261 118661532 0,183,255
chr11 119205287 119205638 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 238 . 119205287 119205638 0,242,255
chr11 119554848 119555105 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 203 . 119554848 119555105 0,207,255
chr11 121526485 121526741 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 179 . 121526485 121526741 0,182,255
chr11 122933528 122933996 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 268 . 122933528 122933996 0,255,236
chr11 124492839 124493099 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 206 . 124492839 124493099 0,210,255
chr11 126173497 126173792 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 228 . 126173497 126173792 0,232,255
chr11 129872557 129872815 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 236 . 129872557 129872815 0,240,255
chr12 498072 498344 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 176 . 498072 498344 0,179,255
chr12 1099748 1100025 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 175 . 1099748 1100025 0,178,255
chr12 2986486 2986902 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 263 . 2986486 2986902 0,255,241
chr12 3861775 3862086 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 152 . 3861775 3862086 0,155,255
chr12 4140805 4141072 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 185 . 4140805 4141072 0,188,255
chr12 6324557 6324825 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 175 . 6324557 6324825 0,178,255
chr12 6493506 6493841 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 207 . 6493506 6493841 0,211,255
chr12 6602632 6602934 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 238 . 6602632 6602934 0,242,255
chr12 6862358 6862677 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 313 . 6862358 6862677 0,255,190
chr12 6976776 6977126 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 175 . 6976776 6977126 0,178,255
chr12 7080125 7080455 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 224 . 7080125 7080455 0,228,255
chr12 9101932 9102270 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 212 . 9101932 9102270 0,216,255
chr12 10765809 10766107 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 203 . 10765809 10766107 0,207,255
chr12 10874932 10875188 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 222 . 10874932 10875188 0,226,255
chr12 11323861 11324117 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 250 . 11323861 11324117 0,255,255
chr12 11873100 11873356 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 11873100 11873356 0,202,255
chr12 12419965 12420222 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 261 . 12419965 12420222 0,255,243
chr12 12849272 12849583 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 330 . 12849272 12849583 0,255,173
chr12 12966390 12966695 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 238 . 12966390 12966695 0,242,255
chr12 13043786 13044115 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 188 . 13043786 13044115 0,191,255
chr12 13254440 13254714 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 221 . 13254440 13254714 0,225,255
chr12 14956066 14956382 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 234 . 14956066 14956382 0,238,255
chr12 16035515 16035837 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 236 . 16035515 16035837 0,240,255
chr12 18877282 18877573 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 152 . 18877282 18877573 0,155,255
chr12 21590886 21591155 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 21590886 21591155 0,174,255
chr12 21654868 21655191 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 21654868 21655191 0,199,255
chr12 22199269 22199525 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 22199269 22199525 0,202,255
chr12 22778214 22778643 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 155 . 22778214 22778643 0,158,255
chr12 25538713 25539002 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 172 . 25538713 25539002 0,175,255
chr12 28284187 28284505 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 200 . 28284187 28284505 0,204,255
chr12 28343877 28344261 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 184 . 28343877 28344261 0,187,255
chr12 29533688 29534023 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 226 . 29533688 29534023 0,230,255
chr12 30948590 30949001 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 182 . 30948590 30949001 0,185,255
chr12 30949198 30949488 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 203 . 30949198 30949488 0,207,255
chr12 32872291 32872735 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 248 . 32872291 32872735 0,252,255
chr12 32908369 32908751 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 327 . 32908369 32908751 0,255,176
chr12 34175531 34175794 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 221 . 34175531 34175794 0,225,255
chr12 38710590 38710934 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 303 . 38710590 38710934 0,255,200
chr12 49524783 49525081 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 241 . 49524783 49525081 0,245,255
chr12 49658991 49659294 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 188 . 49658991 49659294 0,191,255
chr12 51632647 51632927 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 332 . 51632647 51632927 0,255,171
chr12 54718965 54719246 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 251 . 54718965 54719246 0,255,253
chr12 57505206 57505504 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 167 . 57505206 57505504 0,170,255
chr12 57881934 57882231 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 212 . 57881934 57882231 0,216,255
chr12 57940572 57940871 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 155 . 57940572 57940871 0,158,255
chr12 62996387 62996751 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 191 . 62996387 62996751 0,194,255
chr12 69202049 69202306 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 283 . 69202049 69202306 0,255,221
chr12 70636809 70637067 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 222 . 70636809 70637067 0,226,255
chr12 88429418 88429688 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 197 . 88429418 88429688 0,200,255
chr12 90484404 90484727 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 214 . 90484404 90484727 0,218,255
chr12 92172373 92172629 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 201 . 92172373 92172629 0,205,255
chr12 92538868 92539225 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 159 . 92538868 92539225 0,162,255
chr12 93323483 93323906 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 174 . 93323483 93323906 0,177,255
chr12 93623542 93623798 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 178 . 93623542 93623798 0,181,255
chr12 93772203 93772574 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 146 . 93772203 93772574 0,148,255
chr12 93861283 93861720 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 286 . 93861283 93861720 0,255,218
chr12 94071231 94071668 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 270 . 94071231 94071668 0,255,234
chr12 94853366 94853662 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 223 . 94853366 94853662 0,227,255
chr12 95397115 95397371 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 166 . 95397115 95397371 0,169,255
chr12 95867934 95868420 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 426 . 95867934 95868420 0,255,75
chr12 96027711 96027975 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 225 . 96027711 96027975 0,229,255
chr12 96252832 96253176 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 314 . 96252832 96253176 0,255,189
chr12 96820748 96821014 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 180 . 96820748 96821014 0,183,255
chr12 98987551 98988109 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 98987551 98988109 0,202,255
chr12 102270947 102271250 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 174 . 102270947 102271250 0,177,255
chr12 104324234 104324639 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 240 . 104324234 104324639 0,244,255
chr12 104680951 104681537 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 216 . 104680951 104681537 0,220,255
chr12 106696327 106696597 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 106696327 106696597 0,202,255
chr12 107168142 107168428 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 177 . 107168142 107168428 0,180,255
chr12 108954610 108955242 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 108954610 108955242 0,173,255
chr12 109231705 109231987 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 109231705 109231987 0,173,255
chr12 109915217 109915587 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 109915217 109915587 0,197,255
chr12 110011076 110011336 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 110011076 110011336 0,199,255
chr12 110562242 110562659 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 515 . 110562242 110562659 15,255,0
chr12 110685271 110685562 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 129 . 110685271 110685562 0,131,255
chr12 110841536 110841908 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 406 . 110841536 110841908 0,255,95
chr12 110887657 110888100 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 184 . 110887657 110888100 0,187,255
chr12 110939416 110939752 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 154 . 110939416 110939752 0,157,255
chr12 112450646 112450903 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 240 . 112450646 112450903 0,244,255
chr12 112846827 112847332 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 255 . 112846827 112847332 0,255,249
chr12 113376395 113376656 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 113376395 113376656 0,173,255
chr12 113622878 113623489 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 365 . 113622878 113623489 0,255,137
chr12 113905280 113905694 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 175 . 113905280 113905694 0,178,255
chr12 115792176 115792571 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 174 . 115792176 115792571 0,177,255
chr12 121453902 121454187 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 200 . 121453902 121454187 0,204,255
chr12 122238918 122239339 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 193 . 122238918 122239339 0,196,255
chr12 122710022 122710480 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 160 . 122710022 122710480 0,163,255
chr12 122884800 122885076 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 197 . 122884800 122885076 0,200,255
chr12 123011222 123011507 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 284 . 123011222 123011507 0,255,220
chr12 123237407 123237663 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 201 . 123237407 123237663 0,205,255
chr12 123942780 123943037 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 198 . 123942780 123943037 0,201,255
chr12 124086249 124086572 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 242 . 124086249 124086572 0,246,255
chr12 124118428 124118759 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 229 . 124118428 124118759 0,233,255
chr12 131355844 131356168 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 131355844 131356168 0,199,255
chr12 132195349 132195670 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 291 . 132195349 132195670 0,255,213
chr12 133022224 133022489 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 133022224 133022489 0,202,255
chr12 133337730 133338010 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 175 . 133337730 133338010 0,178,255
chr12 133464484 133464808 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 251 . 133464484 133464808 0,255,253
chr13 20438546 20438802 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 151 . 20438546 20438802 0,154,255
chr13 27825779 27826209 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 190 . 27825779 27826209 0,193,255
chr13 44453348 44453625 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 44453348 44453625 0,174,255
chr13 73664296 73664552 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 178 . 73664296 73664552 0,181,255
chr13 74250670 74250926 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 200 . 74250670 74250926 0,204,255
chr13 76123598 76123943 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 390 . 76123598 76123943 0,255,112
chr13 76279293 76279576 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 233 . 76279293 76279576 0,237,255
chr13 79232803 79233059 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 121 . 79232803 79233059 0,123,255
chr13 79980536 79980881 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 79980536 79980881 0,174,255
chr13 80510270 80510700 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 143 . 80510270 80510700 0,145,255
chr13 96705212 96705536 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 195 . 96705212 96705536 0,198,255
chr13 98085801 98086064 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 248 . 98085801 98086064 0,252,255
chr13 99136856 99137156 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 236 . 99136856 99137156 0,240,255
chr13 99235641 99235938 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 99235641 99235938 0,197,255
chr13 99852515 99852863 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 247 . 99852515 99852863 0,251,255
chr13 103248758 103249104 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 425 . 103248758 103249104 0,255,76
chr13 105792139 105792480 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 167 . 105792139 105792480 0,170,255
chr13 110146948 110147254 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 174 . 110146948 110147254 0,177,255
chr13 111357481 111357777 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 111357481 111357777 0,199,255
chr13 111521924 111522442 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 251 . 111521924 111522442 0,255,253
chr13 111568008 111568306 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 175 . 111568008 111568306 0,178,255
chr13 113312095 113312362 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 237 . 113312095 113312362 0,241,255
chr14 21737027 21737538 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 311 . 21737027 21737538 0,255,192
chr14 21851621 21852106 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 217 . 21851621 21852106 0,221,255
chr14 21945432 21945704 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 162 . 21945432 21945704 0,165,255
chr14 23388020 23388330 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 251 . 23388020 23388330 0,255,253
chr14 23398270 23398526 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 23398270 23398526 0,202,255
chr14 23503766 23504027 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 23503766 23504027 0,174,255
chr14 23564075 23564334 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 240 . 23564075 23564334 0,244,255
chr14 23776210 23776525 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 138 . 23776210 23776525 0,140,255
chr14 24025176 24025432 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 178 . 24025176 24025432 0,181,255
chr14 24630522 24630801 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 251 . 24630522 24630801 0,255,253
chr14 24664521 24664823 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 160 . 24664521 24664823 0,163,255
chr14 24682216 24682625 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 218 . 24682216 24682625 0,222,255
chr14 24711581 24711844 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 230 . 24711581 24711844 0,234,255
chr14 24861289 24861559 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 189 . 24861289 24861559 0,192,255
chr14 31160096 31160383 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 166 . 31160096 31160383 0,169,255
chr14 35008542 35008814 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 167 . 35008542 35008814 0,170,255
chr14 35015562 35015940 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 422 . 35015562 35015940 0,255,79
chr14 35025543 35025952 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 449 . 35025543 35025952 0,255,52
chr14 35591255 35591762 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 325 . 35591255 35591762 0,255,178
chr14 45722913 45723184 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 260 . 45722913 45723184 0,255,244
chr14 50052796 50053056 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 232 . 50052796 50053056 0,236,255
chr14 50087031 50087287 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 202 . 50087031 50087287 0,206,255
chr14 50319156 50319570 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 219 . 50319156 50319570 0,223,255
chr14 53197188 53197463 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 180 . 53197188 53197463 0,183,255
chr14 54955041 54955462 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 246 . 54955041 54955462 0,250,255
chr14 55239629 55239949 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 222 . 55239629 55239949 0,226,255
chr14 55518421 55518730 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 380 . 55518421 55518730 0,255,122
chr14 58893873 58894200 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 286 . 58893873 58894200 0,255,218
chr14 60715143 60715638 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 212 . 60715143 60715638 0,216,255
chr14 61447362 61447769 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 305 . 61447362 61447769 0,255,198
chr14 61569948 61570382 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 169 . 61569948 61570382 0,172,255
chr14 62162326 62162654 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 251 . 62162326 62162654 0,255,253
chr14 64108844 64109132 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 345 . 64108844 64109132 0,255,158
chr14 64526595 64526904 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 175 . 64526595 64526904 0,178,255
chr14 64585204 64585543 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 141 . 64585204 64585543 0,143,255
chr14 64804702 64805130 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 187 . 64804702 64805130 0,190,255
chr14 64854263 64854602 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 220 . 64854263 64854602 0,224,255
chr14 65006437 65006821 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 233 . 65006437 65006821 0,237,255
chr14 65381211 65381559 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 380 . 65381211 65381559 0,255,122
chr14 65454028 65454284 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 158 . 65454028 65454284 0,161,255
chr14 68089720 68090005 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 245 . 68089720 68090005 0,249,255
chr14 68141299 68141582 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 219 . 68141299 68141582 0,223,255
chr14 68161776 68162045 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 202 . 68161776 68162045 0,206,255
chr14 69444904 69445386 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 191 . 69444904 69445386 0,194,255
chr14 70233845 70234353 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 371 . 70233845 70234353 0,255,131
chr14 73393511 73393809 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 178 . 73393511 73393809 0,181,255
chr14 73603365 73603694 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 176 . 73603365 73603694 0,179,255
chr14 74417137 74417438 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 124 . 74417137 74417438 0,126,255
chr14 74485369 74485781 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 160 . 74485369 74485781 0,163,255
chr14 75179416 75179673 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 208 . 75179416 75179673 0,212,255
chr14 75593461 75594011 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 200 . 75593461 75594011 0,204,255
chr14 75642928 75643543 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 242 . 75642928 75643543 0,246,255
chr14 75726134 75726506 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 197 . 75726134 75726506 0,200,255
chr14 75760506 75760769 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 169 . 75760506 75760769 0,172,255
chr14 76618347 76618706 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 282 . 76618347 76618706 0,255,222
chr14 78227138 78227468 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 269 . 78227138 78227468 0,255,235
chr14 81999698 82000058 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 181 . 81999698 82000058 0,184,255
chr14 90722953 90723209 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 191 . 90722953 90723209 0,194,255
chr14 90849125 90849500 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 260 . 90849125 90849500 0,255,244
chr14 91976329 91976693 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 253 . 91976329 91976693 0,255,251
chr14 92506030 92506344 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 92506030 92506344 0,173,255
chr14 96000281 96000843 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 204 . 96000281 96000843 0,208,255
chr14 96735033 96735309 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 162 . 96735033 96735309 0,165,255
chr14 100842128 100842437 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 153 . 100842128 100842437 0,156,255
chr14 102276236 102276531 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 102276236 102276531 0,173,255
chr14 102414046 102414312 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 211 . 102414046 102414312 0,215,255
chr14 102414910 102415257 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 164 . 102414910 102415257 0,167,255
chr14 103799816 103800246 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 291 . 103799816 103800246 0,255,213
chr14 105439057 105439414 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 183 . 105439057 105439414 0,186,255
chr14 105947457 105947959 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 296 . 105947457 105947959 0,255,208
chr15 36871311 36871642 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 169 . 36871311 36871642 0,172,255
chr15 42840943 42841314 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 176 . 42840943 42841314 0,179,255
chr15 44084666 44084945 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 167 . 44084666 44084945 0,170,255
chr15 49102867 49103209 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 159 . 49102867 49103209 0,162,255
chr15 57998996 57999252 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 154 . 57998996 57999252 0,157,255
chr15 60770907 60771171 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 214 . 60770907 60771171 0,218,255
chr15 63188487 63188767 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 245 . 63188487 63188767 0,249,255
chr15 66796609 66797188 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 243 . 66796609 66797188 0,247,255
chr15 75316042 75316330 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 219 . 75316042 75316330 0,223,255
chr15 75959566 75959831 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 169 . 75959566 75959831 0,172,255
chr15 79165369 79165736 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 249 . 79165369 79165736 0,253,255
chr15 89010637 89010893 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 89010637 89010893 0,197,255
chr15 101253200 101253462 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 158 . 101253200 101253462 0,161,255
chr15 102501868 102502169 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 214 . 102501868 102502169 0,218,255
chr16 127668 127968 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 151 . 127668 127968 0,154,255
chr16 2255411 2255667 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 234 . 2255411 2255667 0,238,255
chr16 2265323 2265618 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 255 . 2265323 2265618 0,255,249
chr16 2317898 2318165 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 158 . 2317898 2318165 0,161,255
chr16 2827410 2827928 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 304 . 2827410 2827928 0,255,199
chr16 3070509 3070783 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 190 . 3070509 3070783 0,193,255
chr16 4233357 4233681 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 217 . 4233357 4233681 0,221,255
chr16 4321467 4321725 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 238 . 4321467 4321725 0,242,255
chr16 19078907 19079202 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 329 . 19078907 19079202 0,255,174
chr16 22308942 22309198 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 183 . 22308942 22309198 0,186,255
chr16 46654897 46655190 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 191 . 46654897 46655190 0,194,255
chr16 57219461 57219815 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 278 . 57219461 57219815 0,255,226
chr16 57928278 57928534 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 169 . 57928278 57928534 0,172,255
chr16 58426516 58426792 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 173 . 58426516 58426792 0,176,255
chr16 58663338 58663706 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 205 . 58663338 58663706 0,209,255
chr16 67969958 67970230 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 185 . 67969958 67970230 0,188,255
chr16 69788354 69788788 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 263 . 69788354 69788788 0,255,241
chr16 70333075 70333407 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 70333075 70333407 0,197,255
chr16 70557833 70558221 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 239 . 70557833 70558221 0,243,255
chr16 71322858 71323197 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 179 . 71322858 71323197 0,182,255
chr16 71842313 71842872 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 210 . 71842313 71842872 0,214,255
chr16 72698507 72698789 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 153 . 72698507 72698789 0,156,255
chr16 74700329 74700663 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 74700329 74700663 0,174,255
chr16 75299226 75299583 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 266 . 75299226 75299583 0,255,238
chr16 75338742 75339105 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 193 . 75338742 75339105 0,196,255
chr16 75340078 75340479 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 208 . 75340078 75340479 0,212,255
chr16 75467066 75467325 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 159 . 75467066 75467325 0,162,255
chr16 75656642 75657074 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 206 . 75656642 75657074 0,210,255
chr16 77225186 77225454 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 157 . 77225186 77225454 0,160,255
chr16 77322628 77322934 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 119 . 77322628 77322934 0,121,255
chr16 81040535 81041023 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 174 . 81040535 81041023 0,177,255
chr16 81110989 81111354 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 272 . 81110989 81111354 0,255,232
chr16 81615216 81615472 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 158 . 81615216 81615472 0,161,255
chr16 81654686 81655074 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 273 . 81654686 81655074 0,255,231
chr16 82203412 82203728 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 207 . 82203412 82203728 0,211,255
chr17 1619995 1620371 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 281 . 1619995 1620371 0,255,223
chr17 2296646 2296948 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 188 . 2296646 2296948 0,191,255
chr17 7211604 7212076 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 232 . 7211604 7212076 0,236,255
chr17 7476262 7476551 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 181 . 7476262 7476551 0,184,255
chr17 16342525 16342825 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 218 . 16342525 16342825 0,222,255
chr17 17140370 17140866 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 236 . 17140370 17140866 0,240,255
chr17 17380490 17380746 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 142 . 17380490 17380746 0,144,255
chr17 21117105 21117361 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 142 . 21117105 21117361 0,144,255
chr17 25621198 25621492 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 251 . 25621198 25621492 0,255,253
chr17 25680425 25680681 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 157 . 25680425 25680681 0,160,255
chr17 26662846 26663364 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 238 . 26662846 26663364 0,242,255
chr17 26684090 26684426 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 279 . 26684090 26684426 0,255,225
chr17 26898047 26898326 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 122 . 26898047 26898326 0,124,255
chr17 26989248 26989786 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 308 . 26989248 26989786 0,255,195
chr17 27071525 27071820 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 188 . 27071525 27071820 0,191,255
chr17 27278898 27279296 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 306 . 27278898 27279296 0,255,197
chr17 28443819 28444439 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 333 . 28443819 28444439 0,255,170
chr17 28804459 28804910 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 351 . 28804459 28804910 0,255,151
chr17 29159014 29159417 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 261 . 29159014 29159417 0,255,243
chr17 29379612 29379880 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 135 . 29379612 29379880 0,137,255
chr17 29422269 29422529 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 183 . 29422269 29422529 0,186,255
chr17 30677193 30677807 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 286 . 30677193 30677807 0,255,218
chr17 30771546 30772010 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 344 . 30771546 30772010 0,255,159
chr17 33307944 33308206 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 210 . 33307944 33308206 0,214,255
chr17 33446558 33446814 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 278 . 33446558 33446814 0,255,226
chr17 33914470 33915040 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 193 . 33914470 33915040 0,196,255
chr17 34890964 34891262 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 219 . 34890964 34891262 0,223,255
chr17 34900216 34900571 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 34900216 34900571 0,199,255
chr17 35278361 35278799 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 164 . 35278361 35278799 0,167,255
chr17 36003130 36003415 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 218 . 36003130 36003415 0,222,255
chr17 36981693 36982046 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 263 . 36981693 36982046 0,255,241
chr17 37009456 37009797 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 189 . 37009456 37009797 0,192,255
chr17 37356673 37357028 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 187 . 37356673 37357028 0,190,255
chr17 37607236 37607492 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 37607236 37607492 0,202,255
chr17 37617779 37618035 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 178 . 37617779 37618035 0,181,255
chr17 38803802 38804491 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 220 . 38803802 38804491 0,224,255
chr17 39781376 39781635 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 161 . 39781376 39781635 0,164,255
chr17 39845170 39845555 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 529 . 39845170 39845555 29,255,0
chr17 40169030 40169385 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 40169030 40169385 0,173,255
chr17 41393000 41393315 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 296 . 41393000 41393315 0,255,208
chr17 41465856 41466770 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 1000 . 41465856 41466770 255,0,0
chr17 42219409 42219671 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 201 . 42219409 42219671 0,205,255
chr17 42976518 42977068 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 335 . 42976518 42977068 0,255,168
chr17 43128398 43128696 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 179 . 43128398 43128696 0,182,255
chr17 43138716 43138976 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 256 . 43138716 43138976 0,255,248
chr17 43225252 43225588 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 380 . 43225252 43225588 0,255,122
chr17 43238434 43238847 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 397 . 43238434 43238847 0,255,105
chr17 45000482 45000740 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 143 . 45000482 45000740 0,145,255
chr17 47866035 47866358 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 250 . 47866035 47866358 0,255,255
chr17 48106017 48106379 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 179 . 48106017 48106379 0,182,255
chr17 48450245 48450540 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 207 . 48450245 48450540 0,211,255
chr17 48474356 48474774 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 188 . 48474356 48474774 0,191,255
chr17 49198613 49198935 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 223 . 49198613 49198935 0,227,255
chr17 49337456 49337734 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 213 . 49337456 49337734 0,217,255
chr17 56084197 56084557 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 208 . 56084197 56084557 0,212,255
chr17 56736697 56736960 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 217 . 56736697 56736960 0,221,255
chr17 60142900 60143206 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 249 . 60142900 60143206 0,253,255
chr17 61523876 61524259 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 252 . 61523876 61524259 0,255,252
chr17 61904564 61904851 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 61904564 61904851 0,174,255
chr17 62223410 62223830 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 272 . 62223410 62223830 0,255,232
chr17 62501742 62502005 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 204 . 62501742 62502005 0,208,255
chr17 65714142 65714492 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 161 . 65714142 65714492 0,164,255
chr17 66031881 66032258 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 224 . 66031881 66032258 0,228,255
chr17 66243591 66243956 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 159 . 66243591 66243956 0,162,255
chr17 72199972 72200461 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 238 . 72199972 72200461 0,242,255
chr17 72869650 72869994 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 230 . 72869650 72869994 0,234,255
chr17 73257436 73258001 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 206 . 73257436 73258001 0,210,255
chr17 73285792 73286088 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 289 . 73285792 73286088 0,255,215
chr17 73641928 73642207 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 209 . 73641928 73642207 0,213,255
chr17 73717991 73718463 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 140 . 73717991 73718463 0,142,255
chr17 74349987 74350260 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 301 . 74349987 74350260 0,255,202
chr17 74553942 74554259 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 183 . 74553942 74554259 0,186,255
chr17 74722977 74723234 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 214 . 74722977 74723234 0,218,255
chr17 75084888 75085245 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 75084888 75085245 0,199,255
chr17 75136289 75136624 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 289 . 75136289 75136624 0,255,215
chr17 78388950 78389235 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 275 . 78388950 78389235 0,255,229
chr17 78518786 78519171 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 216 . 78518786 78519171 0,220,255
chr17 78830688 78830998 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 261 . 78830688 78830998 0,255,243
chr17 79603531 79603816 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 216 . 79603531 79603816 0,220,255
chr17 79669934 79670212 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 159 . 79669934 79670212 0,162,255
chr17 80231204 80231469 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 153 . 80231204 80231469 0,156,255
chr18 268310 268569 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 143 . 268310 268569 0,145,255
chr18 12702806 12703320 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 208 . 12702806 12703320 0,212,255
chr18 19192367 19192854 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 245 . 19192367 19192854 0,249,255
chr19 1408131 1408405 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 162 . 1408131 1408405 0,165,255
chr19 1591943 1592229 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 197 . 1591943 1592229 0,200,255
chr19 3176629 3176913 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 153 . 3176629 3176913 0,156,255
chr19 3984840 3985185 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 156 . 3984840 3985185 0,159,255
chr19 5790921 5791178 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 183 . 5790921 5791178 0,186,255
chr19 6766676 6766939 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 174 . 6766676 6766939 0,177,255
chr19 8510002 8510287 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 133 . 8510002 8510287 0,135,255
chr19 9251127 9251383 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 205 . 9251127 9251383 0,209,255
chr19 9545781 9546111 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 182 . 9545781 9546111 0,185,255
chr19 9694780 9695145 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 176 . 9694780 9695145 0,179,255
chr19 9785208 9786008 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 189 . 9785208 9786008 0,192,255
chr19 9879422 9879705 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 195 . 9879422 9879705 0,198,255
chr19 9929210 9929711 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 303 . 9929210 9929711 0,255,200
chr19 10305028 10305296 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 162 . 10305028 10305296 0,165,255
chr19 10443879 10444150 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 227 . 10443879 10444150 0,231,255
chr19 10764125 10764467 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 260 . 10764125 10764467 0,255,244
chr19 10946655 10947223 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 240 . 10946655 10947223 0,244,255
chr19 11485337 11485608 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 321 . 11485337 11485608 0,255,182
chr19 12274113 12274406 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 12274113 12274406 0,199,255
chr19 12780263 12780552 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 269 . 12780263 12780552 0,255,235
chr19 12792392 12792648 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 215 . 12792392 12792648 0,219,255
chr19 13049545 13049803 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 157 . 13049545 13049803 0,160,255
chr19 13858857 13859113 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 200 . 13858857 13859113 0,204,255
chr19 14117491 14118086 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 252 . 14117491 14118086 0,255,252
chr19 17326128 17326407 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 249 . 17326128 17326407 0,253,255
chr19 17970772 17971167 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 390 . 17970772 17971167 0,255,112
chr19 18484874 18485222 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 18484874 18485222 0,197,255
chr19 18682863 18683144 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 18682863 18683144 0,197,255
chr19 19029867 19030125 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 192 . 19029867 19030125 0,195,255
chr19 23577762 23578237 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 162 . 23577762 23578237 0,165,255
chr19 24270010 24270374 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 352 . 24270010 24270374 0,255,150
chr19 27731849 27732347 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 575 . 27731849 27732347 76,255,0
chr19 27738411 27738718 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 251 . 27738411 27738718 0,255,253
chr19 36249081 36249415 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 324 . 36249081 36249415 0,255,179
chr19 36631158 36631491 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 191 . 36631158 36631491 0,194,255
chr19 39109923 39110330 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 188 . 39109923 39110330 0,191,255
chr19 39148882 39149161 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 179 . 39148882 39149161 0,182,255
chr19 39390704 39391042 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 153 . 39390704 39391042 0,156,255
chr19 39881395 39881693 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 321 . 39881395 39881693 0,255,182
chr19 41770401 41770766 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 177 . 41770401 41770766 0,180,255
chr19 42579479 42579896 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 142 . 42579479 42579896 0,144,255
chr19 42900816 42901079 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 42900816 42901079 0,202,255
chr19 45981988 45982310 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 45981988 45982310 0,197,255
chr19 47103915 47104206 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 328 . 47103915 47104206 0,255,175
chr19 47634368 47634776 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 163 . 47634368 47634776 0,166,255
chr19 47776967 47777267 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 222 . 47776967 47777267 0,226,255
chr19 48281643 48281922 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 227 . 48281643 48281922 0,231,255
chr19 48949304 48949636 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 232 . 48949304 48949636 0,236,255
chr19 48972606 48972913 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 258 . 48972606 48972913 0,255,246
chr19 49375732 49376096 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 241 . 49375732 49376096 0,245,255
chr19 49990977 49991341 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 200 . 49990977 49991341 0,204,255
chr19 50144146 50144514 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 243 . 50144146 50144514 0,247,255
chr19 50879750 50880044 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 243 . 50879750 50880044 0,247,255
chr19 52531312 52531568 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 52531312 52531568 0,173,255
chr19 52772929 52773320 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 284 . 52772929 52773320 0,255,220
chr19 54704248 54704522 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 232 . 54704248 54704522 0,236,255
chr19 55700434 55700710 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 220 . 55700434 55700710 0,224,255
chr19 55850308 55850596 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 240 . 55850308 55850596 0,244,255
chr19 56826069 56826438 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 228 . 56826069 56826438 0,232,255
chr19 57831921 57832177 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 221 . 57831921 57832177 0,225,255
chr19 58331220 58331476 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 181 . 58331220 58331476 0,184,255
chr19 58873561 58873839 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 217 . 58873561 58873839 0,221,255
chr19 59070586 59070855 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 189 . 59070586 59070855 0,192,255
chr2 1725922 1726223 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 1725922 1726223 0,197,255
chr2 1734094 1734503 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 207 . 1734094 1734503 0,211,255
chr2 9144289 9144853 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 211 . 9144289 9144853 0,215,255
chr2 19547327 19547693 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 153 . 19547327 19547693 0,156,255
chr2 20101131 20101466 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 169 . 20101131 20101466 0,172,255
chr2 20432351 20432635 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 20432351 20432635 0,197,255
chr2 25015951 25016522 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 257 . 25015951 25016522 0,255,247
chr2 25195090 25195475 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 219 . 25195090 25195475 0,223,255
chr2 26100820 26101081 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 180 . 26100820 26101081 0,183,255
chr2 26257060 26257347 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 177 . 26257060 26257347 0,180,255
chr2 26467463 26467752 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 207 . 26467463 26467752 0,211,255
chr2 27545410 27545714 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 219 . 27545410 27545714 0,223,255
chr2 27886200 27886485 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 161 . 27886200 27886485 0,164,255
chr2 28113720 28113994 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 246 . 28113720 28113994 0,250,255
chr2 30670086 30670342 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 173 . 30670086 30670342 0,176,255
chr2 32582539 32582795 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 154 . 32582539 32582795 0,157,255
chr2 38373828 38374086 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 197 . 38373828 38374086 0,200,255
chr2 38978158 38978427 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 261 . 38978158 38978427 0,255,243
chr2 40005954 40006232 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 153 . 40005954 40006232 0,156,255
chr2 42396668 42396996 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 209 . 42396668 42396996 0,213,255
chr2 44588653 44588995 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 368 . 44588653 44588995 0,255,134
chr2 45909361 45909720 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 185 . 45909361 45909720 0,188,255
chr2 47261908 47262256 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 216 . 47261908 47262256 0,220,255
chr2 47403275 47403551 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 189 . 47403275 47403551 0,192,255
chr2 48542228 48542501 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 189 . 48542228 48542501 0,192,255
chr2 54342586 54343018 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 305 . 54342586 54343018 0,255,198
chr2 55459870 55460346 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 301 . 55459870 55460346 0,255,202
chr2 55844369 55844702 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 202 . 55844369 55844702 0,206,255
chr2 55920587 55920881 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 154 . 55920587 55920881 0,157,255
chr2 61372320 61372645 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 230 . 61372320 61372645 0,234,255
chr2 61991026 61991291 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 235 . 61991026 61991291 0,239,255
chr2 62115301 62115629 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 149 . 62115301 62115629 0,151,255
chr2 62132896 62133197 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 162 . 62132896 62133197 0,165,255
chr2 64068295 64068594 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 181 . 64068295 64068594 0,184,255
chr2 67516666 67516971 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 174 . 67516666 67516971 0,177,255
chr2 68289761 68290062 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 205 . 68289761 68290062 0,209,255
chr2 68694782 68695038 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 222 . 68694782 68695038 0,226,255
chr2 70173162 70173616 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 177 . 70173162 70173616 0,180,255
chr2 70313582 70313931 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 251 . 70313582 70313931 0,255,253
chr2 70352104 70352504 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 190 . 70352104 70352504 0,193,255
chr2 70368694 70369190 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 221 . 70368694 70369190 0,225,255
chr2 70520559 70520816 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 173 . 70520559 70520816 0,176,255
chr2 70598596 70598852 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 70598596 70598852 0,199,255
chr2 73461516 73461831 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 231 . 73461516 73461831 0,235,255
chr2 74154078 74154514 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 265 . 74154078 74154514 0,255,239
chr2 74211170 74211645 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 74211170 74211645 0,202,255
chr2 74347432 74347688 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 230 . 74347432 74347688 0,234,255
chr2 74405527 74405975 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 197 . 74405527 74405975 0,200,255
chr2 74425768 74426081 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 282 . 74425768 74426081 0,255,222
chr2 78768399 78768946 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 250 . 78768399 78768946 0,255,255
chr2 81708946 81709202 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 213 . 81708946 81709202 0,217,255
chr2 84686417 84686690 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 295 . 84686417 84686690 0,255,209
chr2 85765437 85766091 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 190 . 85765437 85766091 0,193,255
chr2 86789979 86790461 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 339 . 86789979 86790461 0,255,164
chr2 87303978 87304249 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 209 . 87303978 87304249 0,213,255
chr2 88316035 88316344 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 322 . 88316035 88316344 0,255,181
chr2 95787314 95787712 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 212 . 95787314 95787712 0,216,255
chr2 95831082 95831384 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 252 . 95831082 95831384 0,255,252
chr2 96874247 96874503 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 231 . 96874247 96874503 0,235,255
chr2 101618911 101619236 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 202 . 101618911 101619236 0,206,255
chr2 105953645 105953946 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 202 . 105953645 105953946 0,206,255
chr2 113012246 113012572 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 187 . 113012246 113012572 0,190,255
chr2 113342214 113342478 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 166 . 113342214 113342478 0,169,255
chr2 114040924 114041209 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 190 . 114040924 114041209 0,193,255
chr2 114195412 114195832 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 212 . 114195412 114195832 0,216,255
chr2 135676445 135676727 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 230 . 135676445 135676727 0,234,255
chr2 135809898 135810154 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 202 . 135809898 135810154 0,206,255
chr2 136742743 136743067 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 249 . 136742743 136743067 0,253,255
chr2 150443746 150444185 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 253 . 150443746 150444185 0,255,251
chr2 152145898 152146233 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 169 . 152145898 152146233 0,172,255
chr2 160569134 160569402 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 206 . 160569134 160569402 0,210,255
chr2 162017075 162017410 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 186 . 162017075 162017410 0,189,255
chr2 162165082 162165342 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 146 . 162165082 162165342 0,148,255
chr2 170441009 170441278 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 200 . 170441009 170441278 0,204,255
chr2 178076756 178077115 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 223 . 178076756 178077115 0,227,255
chr2 180871479 180871780 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 185 . 180871479 180871780 0,188,255
chr2 182757083 182757553 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 144 . 182757083 182757553 0,146,255
chr2 197104695 197104951 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 198 . 197104695 197104951 0,201,255
chr2 207630237 207630646 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 207630237 207630646 0,197,255
chr2 217363710 217364157 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 210 . 217363710 217364157 0,214,255
chr2 232328583 232329047 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 175 . 232328583 232329047 0,178,255
chr2 240323060 240323316 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 263 . 240323060 240323316 0,255,241
chr20 388892 389556 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 262 . 388892 389556 0,255,242
chr20 814332 814675 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 297 . 814332 814675 0,255,207
chr20 1099350 1099610 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 145 . 1099350 1099610 0,147,255
chr20 1306097 1306552 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 440 . 1306097 1306552 0,255,61
chr20 1447069 1447405 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 213 . 1447069 1447405 0,217,255
chr20 1757662 1757965 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 1757662 1757965 0,197,255
chr20 2082712 2083269 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 276 . 2082712 2083269 0,255,228
chr20 2450850 2451413 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 334 . 2450850 2451413 0,255,169
chr20 2505484 2505762 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 172 . 2505484 2505762 0,175,255
chr20 2632537 2632978 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 179 . 2632537 2632978 0,182,255
chr20 3140196 3140466 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 218 . 3140196 3140466 0,222,255
chr20 3748750 3749006 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 130 . 3748750 3749006 0,132,255
chr20 3776327 3776674 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 182 . 3776327 3776674 0,185,255
chr20 3801192 3801458 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 252 . 3801192 3801458 0,255,252
chr20 3827602 3828038 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 3827602 3828038 0,197,255
chr20 4424502 4424956 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 203 . 4424502 4424956 0,207,255
chr20 5046418 5046702 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 206 . 5046418 5046702 0,210,255
chr20 5093278 5093599 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 175 . 5093278 5093599 0,178,255
chr20 7327626 7328048 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 298 . 7327626 7328048 0,255,206
chr20 10015752 10016062 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 248 . 10015752 10016062 0,252,255
chr20 13619116 13619484 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 186 . 13619116 13619484 0,189,255
chr20 14269058 14269432 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 303 . 14269058 14269432 0,255,200
chr20 16710698 16711104 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 288 . 16710698 16711104 0,255,216
chr20 17538614 17539098 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 246 . 17538614 17539098 0,250,255
chr20 17830030 17830410 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 215 . 17830030 17830410 0,219,255
chr20 17949764 17950107 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 202 . 17949764 17950107 0,206,255
chr20 18447815 18448150 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 252 . 18447815 18448150 0,255,252
chr20 18487729 18488029 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 174 . 18487729 18488029 0,177,255
chr20 19895209 19895623 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 186 . 19895209 19895623 0,189,255
chr20 19998110 19998454 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 165 . 19998110 19998454 0,168,255
chr20 21283596 21283898 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 21283596 21283898 0,174,255
chr20 22743504 22743834 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 309 . 22743504 22743834 0,255,194
chr20 23031831 23032096 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 153 . 23031831 23032096 0,156,255
chr20 23331567 23331861 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 165 . 23331567 23331861 0,168,255
chr20 23401674 23401976 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 179 . 23401674 23401976 0,182,255
chr20 24973583 24973900 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 144 . 24973583 24973900 0,146,255
chr20 25176469 25176727 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 154 . 25176469 25176727 0,157,255
chr20 25218833 25219209 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 277 . 25218833 25219209 0,255,227
chr20 25388391 25389073 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 225 . 25388391 25389073 0,229,255
chr20 25604126 25604393 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 136 . 25604126 25604393 0,138,255
chr20 25604781 25605311 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 579 . 25604781 25605311 80,255,0
chr20 25676870 25677349 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 290 . 25676870 25677349 0,255,214
chr20 29612046 29612350 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 175 . 29612046 29612350 0,178,255
chr20 30134695 30135072 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 346 . 30134695 30135072 0,255,157
chr20 30135307 30135626 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 189 . 30135307 30135626 0,192,255
chr20 30148268 30148731 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 354 . 30148268 30148731 0,255,148
chr20 30161248 30161646 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 409 . 30161248 30161646 0,255,92
chr20 30192409 30192884 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 311 . 30192409 30192884 0,255,192
chr20 30300838 30301155 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 219 . 30300838 30301155 0,223,255
chr20 30310824 30311251 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 277 . 30310824 30311251 0,255,227
chr20 30327080 30327636 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 334 . 30327080 30327636 0,255,169
chr20 30697269 30698112 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 909 . 30697269 30698112 255,92,0
chr20 30795027 30795293 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 228 . 30795027 30795293 0,232,255
chr20 30795802 30796184 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 331 . 30795802 30796184 0,255,172
chr20 30865646 30865939 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 202 . 30865646 30865939 0,206,255
chr20 31057554 31057828 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 198 . 31057554 31057828 0,201,255
chr20 31176738 31177082 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 223 . 31176738 31177082 0,227,255
chr20 31177332 31177742 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 304 . 31177332 31177742 0,255,199
chr20 32399336 32400064 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 258 . 32399336 32400064 0,255,246
chr20 32581920 32582238 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 177 . 32581920 32582238 0,180,255
chr20 32699361 32699967 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 262 . 32699361 32699967 0,255,242
chr20 32890485 32890750 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 246 . 32890485 32890750 0,250,255
chr20 32951120 32951376 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 234 . 32951120 32951376 0,238,255
chr20 32951651 32951941 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 264 . 32951651 32951941 0,255,240
chr20 33104195 33104480 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 241 . 33104195 33104480 0,245,255
chr20 33680920 33681239 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 173 . 33680920 33681239 0,176,255
chr20 33864945 33865429 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 33864945 33865429 0,199,255
chr20 33871895 33872319 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 163 . 33871895 33872319 0,166,255
chr20 33999412 33999678 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 158 . 33999412 33999678 0,161,255
chr20 34042587 34042858 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 300 . 34042587 34042858 0,255,204
chr20 34252418 34252776 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 273 . 34252418 34252776 0,255,231
chr20 34287345 34287849 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 427 . 34287345 34287849 0,255,74
chr20 34329580 34330115 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 480 . 34329580 34330115 0,255,20
chr20 34330638 34330956 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 34330638 34330956 0,202,255
chr20 34471129 34471851 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 259 . 34471129 34471851 0,255,245
chr20 34541796 34542179 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 222 . 34541796 34542179 0,226,255
chr20 34638217 34638872 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 443 . 34638217 34638872 0,255,58
chr20 34824401 34824794 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 252 . 34824401 34824794 0,255,252
chr20 35401742 35402096 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 438 . 35401742 35402096 0,255,63
chr20 35402415 35402729 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 312 . 35402415 35402729 0,255,191
chr20 35723657 35723924 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 190 . 35723657 35723924 0,193,255
chr20 35807431 35807820 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 317 . 35807431 35807820 0,255,186
chr20 35918010 35918546 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 341 . 35918010 35918546 0,255,162
chr20 36007662 36008024 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 152 . 36007662 36008024 0,155,255
chr20 36155098 36155530 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 190 . 36155098 36155530 0,193,255
chr20 36156227 36156576 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 348 . 36156227 36156576 0,255,155
chr20 36661583 36662382 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 338 . 36661583 36662382 0,255,165
chr20 36772281 36772537 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 162 . 36772281 36772537 0,165,255
chr20 36773065 36773477 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 226 . 36773065 36773477 0,230,255
chr20 37063382 37063945 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 366 . 37063382 37063945 0,255,136
chr20 37075352 37075705 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 267 . 37075352 37075705 0,255,237
chr20 37591051 37591338 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 231 . 37591051 37591338 0,235,255
chr20 39657934 39658474 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 365 . 39657934 39658474 0,255,137
chr20 42086491 42086870 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 646 . 42086491 42086870 148,255,0
chr20 42219291 42219596 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 293 . 42219291 42219596 0,255,211
chr20 42286321 42286618 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 262 . 42286321 42286618 0,255,242
chr20 42410308 42410751 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 218 . 42410308 42410751 0,222,255
chr20 42838764 42839301 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 42838764 42839301 0,174,255
chr20 43104607 43104864 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 184 . 43104607 43104864 0,187,255
chr20 43125116 43125450 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 189 . 43125116 43125450 0,192,255
chr20 43150336 43150669 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 362 . 43150336 43150669 0,255,140
chr20 43514390 43514687 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 260 . 43514390 43514687 0,255,244
chr20 43588663 43588943 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 135 . 43588663 43588943 0,137,255
chr20 44420644 44421011 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 321 . 44420644 44421011 0,255,182
chr20 44441358 44441866 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 294 . 44441358 44441866 0,255,210
chr20 44509895 44510169 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 273 . 44509895 44510169 0,255,231
chr20 44563260 44563653 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 553 . 44563260 44563653 54,255,0
chr20 44600567 44601061 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 700 . 44600567 44601061 204,255,0
chr20 44992690 44993036 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 351 . 44992690 44993036 0,255,151
chr20 46021103 46021518 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 450 . 46021103 46021518 0,255,51
chr20 46767695 46767969 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 180 . 46767695 46767969 0,183,255
chr20 47538382 47538874 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 306 . 47538382 47538874 0,255,197
chr20 47662882 47663186 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 341 . 47662882 47663186 0,255,162
chr20 47835948 47836359 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 356 . 47835948 47836359 0,255,146
chr20 47895283 47895919 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 223 . 47895283 47895919 0,227,255
chr20 48329749 48330066 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 156 . 48329749 48330066 0,159,255
chr20 48532047 48532418 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 269 . 48532047 48532418 0,255,235
chr20 48809139 48809442 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 159 . 48809139 48809442 0,162,255
chr20 48925522 48925867 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 209 . 48925522 48925867 0,213,255
chr20 48937348 48937669 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 48937348 48937669 0,202,255
chr20 49126998 49127305 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 276 . 49126998 49127305 0,255,228
chr20 49407525 49407960 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 192 . 49407525 49407960 0,195,255
chr20 49574720 49575713 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 282 . 49574720 49575713 0,255,222
chr20 49875421 49875994 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 270 . 49875421 49875994 0,255,234
chr20 50383323 50383650 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 275 . 50383323 50383650 0,255,229
chr20 50601963 50602295 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 223 . 50601963 50602295 0,227,255
chr20 52240182 52240448 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 155 . 52240182 52240448 0,158,255
chr20 52390773 52391232 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 219 . 52390773 52391232 0,223,255
chr20 52445524 52445913 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 207 . 52445524 52445913 0,211,255
chr20 52446249 52446740 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 173 . 52446249 52446740 0,176,255
chr20 52749806 52750064 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 133 . 52749806 52750064 0,135,255
chr20 52824349 52824726 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 559 . 52824349 52824726 60,255,0
chr20 55043775 55044116 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 289 . 55043775 55044116 0,255,215
chr20 55204596 55204992 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 158 . 55204596 55204992 0,161,255
chr20 55363077 55363367 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 55363077 55363367 0,199,255
chr20 55926341 55926727 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 250 . 55926341 55926727 0,255,255
chr20 57606845 57607345 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 230 . 57606845 57607345 0,234,255
chr20 60758172 60758573 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 234 . 60758172 60758573 0,238,255
chr20 60877489 60877754 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 252 . 60877489 60877754 0,255,252
chr20 60961696 60962007 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 320 . 60961696 60962007 0,255,183
chr20 61273239 61273512 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 175 . 61273239 61273512 0,178,255
chr20 61568710 61569144 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 229 . 61568710 61569144 0,233,255
chr20 62257625 62257990 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 283 . 62257625 62257990 0,255,221
chr20 62330878 62331269 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 315 . 62330878 62331269 0,255,188
chr20 62495873 62496298 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 270 . 62495873 62496298 0,255,234
chr20 62496755 62497152 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 184 . 62496755 62497152 0,187,255
chr20 62587302 62587639 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 183 . 62587302 62587639 0,186,255
chr22 16192607 16192871 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 179 . 16192607 16192871 0,182,255
chr22 18121593 18121965 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 174 . 18121593 18121965 0,177,255
chr22 19466705 19467190 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 261 . 19466705 19467190 0,255,243
chr22 21356179 21356456 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 220 . 21356179 21356456 0,224,255
chr22 21983777 21984218 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 296 . 21983777 21984218 0,255,208
chr22 24129212 24129480 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 306 . 24129212 24129480 0,255,197
chr22 24951529 24951807 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 216 . 24951529 24951807 0,220,255
chr22 26879323 26879700 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 236 . 26879323 26879700 0,240,255
chr22 27069086 27069508 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 245 . 27069086 27069508 0,249,255
chr22 29195616 29196171 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 239 . 29195616 29196171 0,243,255
chr22 29663982 29664254 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 29663982 29664254 0,173,255
chr22 31226474 31226765 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 139 . 31226474 31226765 0,141,255
chr22 35796185 35796582 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 243 . 35796185 35796582 0,247,255
chr22 36044579 36044959 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 256 . 36044579 36044959 0,255,248
chr22 36448352 36448746 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 205 . 36448352 36448746 0,209,255
chr22 36462116 36462397 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 205 . 36462116 36462397 0,209,255
chr22 36877485 36878037 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 301 . 36877485 36878037 0,255,202
chr22 36924687 36925019 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 192 . 36924687 36925019 0,195,255
chr22 38082321 38082731 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 266 . 38082321 38082731 0,255,238
chr22 38172583 38173044 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 317 . 38172583 38173044 0,255,186
chr22 38244903 38245225 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 180 . 38244903 38245225 0,183,255
chr22 38301515 38301799 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 159 . 38301515 38301799 0,162,255
chr22 38453203 38453675 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 160 . 38453203 38453675 0,163,255
chr22 38598746 38599136 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 148 . 38598746 38599136 0,150,255
chr22 38695165 38695428 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 185 . 38695165 38695428 0,188,255
chr22 38901997 38902316 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 391 . 38901997 38902316 0,255,111
chr22 39052352 39052745 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 360 . 39052352 39052745 0,255,142
chr22 39078025 39078392 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 178 . 39078025 39078392 0,181,255
chr22 39916512 39916960 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 269 . 39916512 39916960 0,255,235
chr22 39928428 39928684 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 39928428 39928684 0,197,255
chr22 41047847 41048117 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 300 . 41047847 41048117 0,255,204
chr22 41048322 41048755 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 348 . 41048322 41048755 0,255,155
chr22 42063097 42063376 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 160 . 42063097 42063376 0,163,255
chr22 42486393 42486709 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 253 . 42486393 42486709 0,255,251
chr22 42977559 42977934 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 240 . 42977559 42977934 0,244,255
chr22 46315262 46315536 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 137 . 46315262 46315536 0,139,255
chr22 46409765 46410187 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 186 . 46409765 46410187 0,189,255
chr22 51020966 51021259 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 248 . 51020966 51021259 0,252,255
chr3 10068127 10068428 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 265 . 10068127 10068428 0,255,239
chr3 12882532 12882828 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 165 . 12882532 12882828 0,168,255
chr3 12883038 12883294 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 235 . 12883038 12883294 0,239,255
chr3 23958781 23959122 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 193 . 23958781 23959122 0,196,255
chr3 46734608 46734974 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 191 . 46734608 46734974 0,194,255
chr3 48507365 48507893 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 224 . 48507365 48507893 0,228,255
chr3 48514195 48514451 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 181 . 48514195 48514451 0,184,255
chr3 48700639 48701004 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 204 . 48700639 48701004 0,208,255
chr3 48754272 48754530 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 211 . 48754272 48754530 0,215,255
chr3 50126423 50126744 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 263 . 50126423 50126744 0,255,241
chr3 56716694 56717086 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 180 . 56716694 56717086 0,183,255
chr3 59035334 59035597 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 203 . 59035334 59035597 0,207,255
chr3 73159825 73160229 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 1000 . 73159825 73160229 255,0,0
chr3 93699100 93699356 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 154 . 93699100 93699356 0,157,255
chr3 98241292 98241685 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 202 . 98241292 98241685 0,206,255
chr3 99536464 99536797 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 157 . 99536464 99536797 0,160,255
chr3 101404971 101405370 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 234 . 101404971 101405370 0,238,255
chr3 119814122 119814413 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 251 . 119814122 119814413 0,255,253
chr3 120315238 120315517 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 195 . 120315238 120315517 0,198,255
chr3 121468213 121468494 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 216 . 121468213 121468494 0,220,255
chr3 122283350 122283625 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 209 . 122283350 122283625 0,213,255
chr3 123679788 123680044 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 198 . 123679788 123680044 0,201,255
chr3 127317316 127317849 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 255 . 127317316 127317849 0,255,249
chr3 127842230 127842554 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 188 . 127842230 127842554 0,191,255
chr3 128597980 128598270 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 128597980 128598270 0,202,255
chr3 128902176 128902499 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 142 . 128902176 128902499 0,144,255
chr3 130612303 130612685 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 179 . 130612303 130612685 0,182,255
chr3 130745776 130746067 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 214 . 130745776 130746067 0,218,255
chr3 131221313 131221676 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 232 . 131221313 131221676 0,236,255
chr3 137906139 137906410 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 216 . 137906139 137906410 0,220,255
chr3 141086807 141087074 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 182 . 141086807 141087074 0,185,255
chr3 142166427 142166798 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 200 . 142166427 142166798 0,204,255
chr3 149530566 149530827 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 198 . 149530566 149530827 0,201,255
chr3 154041885 154042189 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 200 . 154041885 154042189 0,204,255
chr3 156543559 156543917 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 258 . 156543559 156543917 0,255,246
chr3 156544157 156544487 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 197 . 156544157 156544487 0,200,255
chr3 156878138 156878458 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 220 . 156878138 156878458 0,224,255
chr3 160283601 160283861 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 220 . 160283601 160283861 0,224,255
chr3 169899105 169899433 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 264 . 169899105 169899433 0,255,240
chr3 170587490 170587864 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 170587490 170587864 0,199,255
chr3 183966888 183967162 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 187 . 183966888 183967162 0,190,255
chr3 185655423 185655700 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 202 . 185655423 185655700 0,206,255
chr3 186501030 186501310 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 232 . 186501030 186501310 0,236,255
chr3 186501396 186501751 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 198 . 186501396 186501751 0,201,255
chr3 187463307 187463563 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 244 . 187463307 187463563 0,248,255
chr3 187871057 187871386 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 178 . 187871057 187871386 0,181,255
chr3 194304820 194305076 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 194304820 194305076 0,199,255
chr3 194392979 194393270 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 251 . 194392979 194393270 0,255,253
chr3 197518156 197518427 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 231 . 197518156 197518427 0,235,255
chr3 197677218 197677579 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 178 . 197677218 197677579 0,181,255
chr4 124422 124694 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 185 . 124422 124694 0,188,255
chr4 4543426 4543682 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 217 . 4543426 4543682 0,221,255
chr4 8441883 8442237 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 179 . 8441883 8442237 0,182,255
chr4 24585728 24586115 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 287 . 24585728 24586115 0,255,217
chr4 38190813 38191113 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 247 . 38190813 38191113 0,251,255
chr4 39460074 39460409 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 197 . 39460074 39460409 0,200,255
chr4 39978399 39978751 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 39978399 39978751 0,199,255
chr4 48018859 48019179 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 230 . 48018859 48019179 0,234,255
chr4 48833198 48833632 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 314 . 48833198 48833632 0,255,189
chr4 54243937 54244260 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 167 . 54243937 54244260 0,170,255
chr4 108745477 108745744 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 153 . 108745477 108745744 0,156,255
chr5 442880 443139 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 442880 443139 0,197,255
chr5 892255 892755 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 265 . 892255 892755 0,255,239
chr5 912172 912508 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 186 . 912172 912508 0,189,255
chr5 1950557 1950831 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 229 . 1950557 1950831 0,233,255
chr5 5025618 5025890 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 203 . 5025618 5025890 0,207,255
chr5 6378237 6378636 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 253 . 6378237 6378636 0,255,251
chr5 6632804 6633453 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 413 . 6632804 6633453 0,255,88
chr5 6712443 6712920 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 172 . 6712443 6712920 0,175,255
chr5 8457871 8458226 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 235 . 8457871 8458226 0,239,255
chr5 9046412 9046806 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 181 . 9046412 9046806 0,184,255
chr5 9379922 9380237 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 217 . 9379922 9380237 0,221,255
chr5 10249816 10250408 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 401 . 10249816 10250408 0,255,100
chr5 10250470 10250869 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 229 . 10250470 10250869 0,233,255
chr5 13567433 13567858 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 336 . 13567433 13567858 0,255,167
chr5 14012055 14012392 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 258 . 14012055 14012392 0,255,246
chr5 16466129 16466483 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 168 . 16466129 16466483 0,171,255
chr5 16492948 16493363 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 195 . 16492948 16493363 0,198,255
chr5 23411255 23411730 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 23411255 23411730 0,197,255
chr5 23506997 23507450 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 193 . 23506997 23507450 0,196,255
chr5 23528016 23528302 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 231 . 23528016 23528302 0,235,255
chr5 23631711 23632176 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 246 . 23631711 23632176 0,250,255
chr5 27316006 27316431 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 229 . 27316006 27316431 0,233,255
chr5 27328368 27328624 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 140 . 27328368 27328624 0,142,255
chr5 27403526 27403944 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 201 . 27403526 27403944 0,205,255
chr5 31855119 31855403 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 150 . 31855119 31855403 0,153,255
chr5 32060290 32060585 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 217 . 32060290 32060585 0,221,255
chr5 32174133 32174427 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 279 . 32174133 32174427 0,255,225
chr5 32174533 32174827 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 289 . 32174533 32174827 0,255,215
chr5 32444252 32444565 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 288 . 32444252 32444565 0,255,216
chr5 32585747 32586126 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 321 . 32585747 32586126 0,255,182
chr5 33049386 33049696 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 163 . 33049386 33049696 0,166,255
chr5 33312682 33313232 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 274 . 33312682 33313232 0,255,230
chr5 33440025 33440616 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 216 . 33440025 33440616 0,220,255
chr5 33441124 33441736 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 245 . 33441124 33441736 0,249,255
chr5 34147696 34147985 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 188 . 34147696 34147985 0,191,255
chr5 34571011 34571301 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 216 . 34571011 34571301 0,220,255
chr5 34586008 34586329 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 316 . 34586008 34586329 0,255,187
chr5 34586930 34587783 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 176 . 34586930 34587783 0,179,255
chr5 34657250 34657506 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 34657250 34657506 0,174,255
chr5 34915830 34916227 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 340 . 34915830 34916227 0,255,163
chr5 34930089 34930440 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 223 . 34930089 34930440 0,227,255
chr5 36151559 36151934 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 207 . 36151559 36151934 0,211,255
chr5 36241310 36241622 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 36241310 36241622 0,174,255
chr5 36658075 36658388 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 123 . 36658075 36658388 0,125,255
chr5 36689898 36690194 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 136 . 36689898 36690194 0,138,255
chr5 36877076 36877629 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 36877076 36877629 0,199,255
chr5 37249008 37249422 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 261 . 37249008 37249422 0,255,243
chr5 37370715 37371096 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 207 . 37370715 37371096 0,211,255
chr5 37810839 37811245 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 182 . 37810839 37811245 0,185,255
chr5 38659951 38660479 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 339 . 38659951 38660479 0,255,164
chr5 38845423 38845817 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 320 . 38845423 38845817 0,255,183
chr5 38846311 38846755 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 327 . 38846311 38846755 0,255,176
chr5 39256115 39256581 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 208 . 39256115 39256581 0,212,255
chr5 39787411 39787774 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 253 . 39787411 39787774 0,255,251
chr5 40755616 40755972 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 279 . 40755616 40755972 0,255,225
chr5 40834553 40835223 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 376 . 40834553 40835223 0,255,126
chr5 40835582 40836008 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 271 . 40835582 40836008 0,255,233
chr5 40841185 40841827 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 329 . 40841185 40841827 0,255,174
chr5 41869838 41870541 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 301 . 41869838 41870541 0,255,202
chr5 41904481 41904926 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 398 . 41904481 41904926 0,255,104
chr5 41924981 41925960 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 365 . 41924981 41925960 0,255,137
chr5 42949755 42950329 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 164 . 42949755 42950329 0,167,255
chr5 42951099 42951412 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 271 . 42951099 42951412 0,255,233
chr5 42984798 42985411 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 211 . 42984798 42985411 0,215,255
chr5 43007923 43008179 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 155 . 43007923 43008179 0,158,255
chr5 43009207 43009717 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 182 . 43009207 43009717 0,185,255
chr5 43065801 43066065 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 161 . 43065801 43066065 0,164,255
chr5 43066261 43066891 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 286 . 43066261 43066891 0,255,218
chr5 43120937 43121476 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 232 . 43120937 43121476 0,236,255
chr5 43121822 43122122 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 178 . 43121822 43122122 0,181,255
chr5 43313207 43313500 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 237 . 43313207 43313500 0,241,255
chr5 43314085 43314557 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 166 . 43314085 43314557 0,169,255
chr5 43396558 43397263 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 278 . 43396558 43397263 0,255,226
chr5 43483502 43483853 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 321 . 43483502 43483853 0,255,182
chr5 43484045 43484479 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 467 . 43484045 43484479 0,255,33
chr5 43514513 43515153 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 353 . 43514513 43515153 0,255,149
chr5 43556376 43556677 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 189 . 43556376 43556677 0,192,255
chr5 68665315 68665571 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 185 . 68665315 68665571 0,188,255
chr5 81573680 81574039 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 233 . 81573680 81574039 0,237,255
chr5 96143333 96143691 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 172 . 96143333 96143691 0,175,255
chr5 96519082 96519350 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 180 . 96519082 96519350 0,183,255
chr5 102455427 102455700 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 145 . 102455427 102455700 0,147,255
chr5 111496619 111496885 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 223 . 111496619 111496885 0,227,255
chr5 114598206 114598506 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 114598206 114598506 0,174,255
chr5 121297747 121298040 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 185 . 121297747 121298040 0,188,255
chr5 131132366 131132622 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 163 . 131132366 131132622 0,166,255
chr5 132361959 132362233 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 227 . 132361959 132362233 0,231,255
chr5 132387850 132388329 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 186 . 132387850 132388329 0,189,255
chr5 133561369 133561733 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 204 . 133561369 133561733 0,208,255
chr5 133983888 133984155 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 181 . 133983888 133984155 0,184,255
chr5 137673645 137673957 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 226 . 137673645 137673957 0,230,255
chr5 137878454 137878768 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 191 . 137878454 137878768 0,194,255
chr5 137910689 137911039 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 206 . 137910689 137911039 0,210,255
chr5 138533500 138533807 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 164 . 138533500 138533807 0,167,255
chr5 138609902 138610178 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 228 . 138609902 138610178 0,232,255
chr5 138629504 138629951 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 201 . 138629504 138629951 0,205,255
chr5 138677585 138677935 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 233 . 138677585 138677935 0,237,255
chr5 139936556 139936824 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 155 . 139936556 139936824 0,158,255
chr5 140699986 140700279 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 242 . 140699986 140700279 0,246,255
chr5 140998162 140998431 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 140998162 140998431 0,174,255
chr5 141228788 141229152 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 173 . 141228788 141229152 0,176,255
chr5 141229476 141229846 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 240 . 141229476 141229846 0,244,255
chr5 141348791 141349047 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 162 . 141348791 141349047 0,165,255
chr5 145561665 145561939 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 150 . 145561665 145561939 0,153,255
chr5 145826974 145827609 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 306 . 145826974 145827609 0,255,197
chr5 148930442 148930761 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 184 . 148930442 148930761 0,187,255
chr5 149828863 149829125 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 144 . 149828863 149829125 0,146,255
chr5 158689970 158690226 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 151 . 158689970 158690226 0,154,255
chr5 159826756 159827018 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 159826756 159827018 0,202,255
chr5 169010839 169011147 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 169010839 169011147 0,197,255
chr5 172160223 172160498 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 137 . 172160223 172160498 0,139,255
chr5 172331520 172331933 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 150 . 172331520 172331933 0,153,255
chr5 179050185 179050507 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 236 . 179050185 179050507 0,240,255
chr5 180258277 180258559 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 181 . 180258277 180258559 0,184,255
chr6 2990303 2990605 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 2990303 2990605 0,199,255
chr6 6804357 6804649 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 155 . 6804357 6804649 0,158,255
chr6 10441937 10442249 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 192 . 10441937 10442249 0,195,255
chr6 10694505 10694761 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 136 . 10694505 10694761 0,138,255
chr6 10723483 10723802 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 167 . 10723483 10723802 0,170,255
chr6 13574876 13575144 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 186 . 13574876 13575144 0,189,255
chr6 17706414 17706671 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 191 . 17706414 17706671 0,194,255
chr6 18352722 18353001 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 265 . 18352722 18353001 0,255,239
chr6 24720643 24720960 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 249 . 24720643 24720960 0,253,255
chr6 24775210 24775469 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 238 . 24775210 24775469 0,242,255
chr6 26224556 26224939 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 191 . 26224556 26224939 0,194,255
chr6 26286040 26286365 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 182 . 26286040 26286365 0,185,255
chr6 27099988 27100261 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 156 . 27099988 27100261 0,159,255
chr6 28048087 28048381 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 201 . 28048087 28048381 0,205,255
chr6 30181520 30181831 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 151 . 30181520 30181831 0,154,255
chr6 30294262 30294577 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 166 . 30294262 30294577 0,169,255
chr6 30457383 30457670 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 219 . 30457383 30457670 0,223,255
chr6 30539226 30539519 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 230 . 30539226 30539519 0,234,255
chr6 31082679 31082986 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 31082679 31082986 0,202,255
chr6 31509912 31510212 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 210 . 31509912 31510212 0,214,255
chr6 31620477 31620744 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 256 . 31620477 31620744 0,255,248
chr6 32163822 32164253 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 400 . 32163822 32164253 0,255,102
chr6 33175822 33176121 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 156 . 33175822 33176121 0,159,255
chr6 33239163 33239570 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 188 . 33239163 33239570 0,191,255
chr6 33679129 33679475 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 294 . 33679129 33679475 0,255,210
chr6 34204026 34204379 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 176 . 34204026 34204379 0,179,255
chr6 34393118 34393375 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 139 . 34393118 34393375 0,141,255
chr6 34625111 34625532 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 164 . 34625111 34625532 0,167,255
chr6 34724625 34725075 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 231 . 34724625 34725075 0,235,255
chr6 35436299 35436637 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 136 . 35436299 35436637 0,138,255
chr6 35465327 35465608 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 233 . 35465327 35465608 0,237,255
chr6 36514843 36515099 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 164 . 36514843 36515099 0,167,255
chr6 36842393 36842790 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 160 . 36842393 36842790 0,163,255
chr6 37225634 37225966 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 248 . 37225634 37225966 0,252,255
chr6 37786826 37787122 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 183 . 37786826 37787122 0,186,255
chr6 38723354 38723626 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 219 . 38723354 38723626 0,223,255
chr6 41604911 41605215 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 195 . 41604911 41605215 0,198,255
chr6 41755434 41755723 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 187 . 41755434 41755723 0,190,255
chr6 42751156 42751585 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 238 . 42751156 42751585 0,242,255
chr6 42858253 42858533 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 230 . 42858253 42858533 0,234,255
chr6 43597346 43597615 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 150 . 43597346 43597615 0,153,255
chr6 44214941 44215373 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 189 . 44214941 44215373 0,192,255
chr6 44355404 44355732 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 203 . 44355404 44355732 0,207,255
chr6 52285278 52285564 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 242 . 52285278 52285564 0,246,255
chr6 53167136 53167426 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 198 . 53167136 53167426 0,201,255
chr6 53224477 53224759 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 250 . 53224477 53224759 0,255,255
chr6 135819101 135819425 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 183 . 135819101 135819425 0,186,255
chr7 578253 578871 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 227 . 578253 578871 0,231,255
chr7 871651 871923 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 235 . 871651 871923 0,239,255
chr7 1014850 1015120 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 218 . 1014850 1015120 0,222,255
chr7 2000952 2001229 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 154 . 2000952 2001229 0,157,255
chr7 2393695 2394393 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 481 . 2393695 2394393 0,255,19
chr7 2595135 2595401 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 299 . 2595135 2595401 0,255,205
chr7 2861931 2862187 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 163 . 2861931 2862187 0,166,255
chr7 2902999 2903307 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 186 . 2902999 2903307 0,189,255
chr7 2913429 2913751 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 335 . 2913429 2913751 0,255,168
chr7 5436536 5436838 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 210 . 5436536 5436838 0,214,255
chr7 6617168 6617458 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 6617168 6617458 0,197,255
chr7 10979739 10980029 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 229 . 10979739 10980029 0,233,255
chr7 11013009 11013303 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 356 . 11013009 11013303 0,255,146
chr7 12726616 12726902 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 181 . 12726616 12726902 0,184,255
chr7 17979694 17980007 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 224 . 17979694 17980007 0,228,255
chr7 18548997 18549260 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 217 . 18548997 18549260 0,221,255
chr7 19748226 19748552 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 157 . 19748226 19748552 0,160,255
chr7 21467156 21467466 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 280 . 21467156 21467466 0,255,224
chr7 21985477 21985774 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 21985477 21985774 0,199,255
chr7 23339024 23339280 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 23339024 23339280 0,173,255
chr7 23571242 23571556 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 311 . 23571242 23571556 0,255,192
chr7 24795703 24796064 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 121 . 24795703 24796064 0,123,255
chr7 24860731 24861047 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 140 . 24860731 24861047 0,142,255
chr7 25164244 25164586 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 205 . 25164244 25164586 0,209,255
chr7 25980322 25980668 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 165 . 25980322 25980668 0,168,255
chr7 27223724 27223996 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 184 . 27223724 27223996 0,187,255
chr7 27779821 27780277 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 335 . 27779821 27780277 0,255,168
chr7 34034245 34034503 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 218 . 34034245 34034503 0,222,255
chr7 40939464 40939770 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 235 . 40939464 40939770 0,239,255
chr7 44417828 44418206 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 195 . 44417828 44418206 0,198,255
chr7 44530239 44530566 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 341 . 44530239 44530566 0,255,162
chr7 44836709 44837061 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 258 . 44836709 44837061 0,255,246
chr7 44888187 44888609 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 162 . 44888187 44888609 0,165,255
chr7 45150702 45151206 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 181 . 45150702 45151206 0,184,255
chr7 45808783 45809058 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 224 . 45808783 45809058 0,228,255
chr7 46691764 46692164 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 151 . 46691764 46692164 0,154,255
chr7 54827147 54827403 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 159 . 54827147 54827403 0,162,255
chr7 55433690 55434041 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 398 . 55433690 55434041 0,255,104
chr7 56173681 56174040 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 232 . 56173681 56174040 0,236,255
chr7 61968886 61969555 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 232 . 61968886 61969555 0,236,255
chr7 64126643 64126899 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 163 . 64126643 64126899 0,166,255
chr7 64838848 64839253 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 200 . 64838848 64839253 0,204,255
chr7 65958197 65958499 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 248 . 65958197 65958499 0,252,255
chr7 66093324 66093582 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 204 . 66093324 66093582 0,208,255
chr7 66310117 66310423 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 220 . 66310117 66310423 0,224,255
chr7 72395198 72395490 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 204 . 72395198 72395490 0,208,255
chr7 75676847 75677141 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 190 . 75676847 75677141 0,193,255
chr7 76067540 76067893 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 178 . 76067540 76067893 0,181,255
chr7 77167052 77167621 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 186 . 77167052 77167621 0,189,255
chr7 79940866 79941503 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 204 . 79940866 79941503 0,208,255
chr7 92219370 92219693 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 261 . 92219370 92219693 0,255,243
chr7 93633358 93633624 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 207 . 93633358 93633624 0,211,255
chr7 96338843 96339106 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 210 . 96338843 96339106 0,214,255
chr7 99006632 99007051 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 210 . 99006632 99007051 0,214,255
chr7 99063414 99063694 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 164 . 99063414 99063694 0,167,255
chr7 99097439 99097734 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 99097439 99097734 0,174,255
chr7 99613422 99613774 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 221 . 99613422 99613774 0,225,255
chr7 99698665 99698950 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 185 . 99698665 99698950 0,188,255
chr7 100465035 100465380 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 297 . 100465035 100465380 0,255,207
chr7 102004555 102004811 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 102004555 102004811 0,199,255
chr7 102119015 102119362 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 233 . 102119015 102119362 0,237,255
chr7 102212611 102212993 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 251 . 102212611 102212993 0,255,253
chr7 102515801 102516057 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 188 . 102515801 102516057 0,191,255
chr7 102937923 102938222 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 208 . 102937923 102938222 0,212,255
chr7 104586118 104586402 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 104586118 104586402 0,199,255
chr7 104624164 104624811 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 193 . 104624164 104624811 0,196,255
chr7 105925947 105926369 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 265 . 105925947 105926369 0,255,239
chr7 111202022 111202302 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 158 . 111202022 111202302 0,161,255
chr7 115850985 115851356 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 194 . 115850985 115851356 0,197,255
chr7 128694727 128695236 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 139 . 128694727 128695236 0,141,255
chr7 130080606 130080889 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 212 . 130080606 130080889 0,216,255
chr7 131012742 131013062 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 257 . 131012742 131013062 0,255,247
chr7 132766481 132766737 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 224 . 132766481 132766737 0,228,255
chr7 134576333 134576614 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 168 . 134576333 134576614 0,171,255
chr7 135242463 135243238 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 232 . 135242463 135243238 0,236,255
chr7 135347317 135347592 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 230 . 135347317 135347592 0,234,255
chr7 139025885 139026293 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 214 . 139025885 139026293 0,218,255
chr7 139043927 139044320 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 164 . 139043927 139044320 0,167,255
chr7 140714368 140714681 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 224 . 140714368 140714681 0,228,255
chr7 141438222 141438480 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 182 . 141438222 141438480 0,185,255
chr7 142985622 142985932 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 142985622 142985932 0,173,255
chr7 148638046 148638339 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 157 . 148638046 148638339 0,160,255
chr7 156433530 156433841 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 156433530 156433841 0,199,255
chr7 157085746 157086085 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 167 . 157085746 157086085 0,170,255
chr7 158496971 158497352 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 183 . 158496971 158497352 0,186,255
chr7_gl000195_random 86288 86561 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 165 . 86288 86561 0,168,255
chr7_gl000195_random 137958 138466 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 498 . 137958 138466 0,255,2
chr8 1704108 1704493 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 180 . 1704108 1704493 0,183,255
chr8 21998962 21999261 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 264 . 21998962 21999261 0,255,240
chr8 22193243 22193499 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 157 . 22193243 22193499 0,160,255
chr8 22455999 22456359 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 154 . 22455999 22456359 0,157,255
chr8 22526073 22526598 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 203 . 22526073 22526598 0,207,255
chr8 29940092 29940433 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 227 . 29940092 29940433 0,231,255
chr8 48872903 48873181 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 251 . 48872903 48873181 0,255,253
chr8 48920538 48920818 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 224 . 48920538 48920818 0,228,255
chr8 54793817 54794073 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 139 . 54793817 54794073 0,141,255
chr8 55047853 55048163 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 208 . 55047853 55048163 0,212,255
chr8 56986559 56987021 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 278 . 56986559 56987021 0,255,226
chr8 64081161 64081478 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 204 . 64081161 64081478 0,208,255
chr8 67025895 67026218 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 261 . 67025895 67026218 0,255,243
chr8 67435152 67435408 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 251 . 67435152 67435408 0,255,253
chr8 67837213 67837694 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 198 . 67837213 67837694 0,201,255
chr8 67974107 67974575 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 185 . 67974107 67974575 0,188,255
chr8 70060515 70060771 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 159 . 70060515 70060771 0,162,255
chr8 74324869 74325149 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 132 . 74324869 74325149 0,134,255
chr8 80942227 80942502 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 255 . 80942227 80942502 0,255,249
chr8 87520621 87520877 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 201 . 87520621 87520877 0,205,255
chr8 90995860 90996250 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 188 . 90995860 90996250 0,191,255
chr8 92081841 92082139 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 177 . 92081841 92082139 0,180,255
chr8 94752707 94753138 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 138 . 94752707 94753138 0,140,255
chr8 94886549 94886831 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 199 . 94886549 94886831 0,202,255
chr8 95004124 95004417 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 190 . 95004124 95004417 0,193,255
chr8 97247310 97247622 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 138 . 97247310 97247622 0,140,255
chr8 99057308 99057755 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 296 . 99057308 99057755 0,255,208
chr8 99830069 99830336 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 153 . 99830069 99830336 0,156,255
chr8 101170263 101170579 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 186 . 101170263 101170579 0,189,255
chr8 101963901 101964174 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 173 . 101963901 101964174 0,176,255
chr8 109260481 109260914 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 231 . 109260481 109260914 0,235,255
chr8 117767738 117767996 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 233 . 117767738 117767996 0,237,255
chr8 121457140 121457635 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 145 . 121457140 121457635 0,147,255
chr8 124408220 124408886 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 162 . 124408220 124408886 0,165,255
chr8 124720454 124720763 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 216 . 124720454 124720763 0,220,255
chr8 125550885 125551141 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 187 . 125550885 125551141 0,190,255
chr8 125764497 125764878 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 247 . 125764497 125764878 0,251,255
chr8 125859887 125860218 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 177 . 125859887 125860218 0,180,255
chr8 126104129 126104394 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 126104129 126104394 0,174,255
chr8 126232181 126232489 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 146 . 126232181 126232489 0,148,255
chr8 129189705 129189977 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 213 . 129189705 129189977 0,217,255
chr8 134309982 134310282 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 242 . 134309982 134310282 0,246,255
chr8 134931250 134931509 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 169 . 134931250 134931509 0,172,255
chr8 142137823 142138263 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 283 . 142137823 142138263 0,255,221
chr8 142163867 142164183 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 142163867 142164183 0,173,255
chr8 145515701 145516009 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 209 . 145515701 145516009 0,213,255
chr8 145653350 145653657 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 175 . 145653350 145653657 0,178,255
chr8 146053000 146053484 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 271 . 146053000 146053484 0,255,233
chr9 178670 178975 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 253 . 178670 178975 0,255,251
chr9 3526582 3527076 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 3526582 3527076 0,173,255
chr9 4984412 4984691 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 166 . 4984412 4984691 0,169,255
chr9 6566844 6567124 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 297 . 6566844 6567124 0,255,207
chr9 11064595 11064987 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 215 . 11064595 11064987 0,219,255
chr9 15510962 15511218 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 222 . 15510962 15511218 0,226,255
chr9 19379641 19380131 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 274 . 19379641 19380131 0,255,230
chr9 21335063 21335413 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 439 . 21335063 21335413 0,255,62
chr9 26947220 26947529 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 213 . 26947220 26947529 0,217,255
chr9 27528672 27528978 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 27528672 27528978 0,173,255
chr9 27771360 27771658 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 206 . 27771360 27771658 0,210,255
chr9 31908689 31908997 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 181 . 31908689 31908997 0,184,255
chr9 33290012 33290322 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 316 . 33290012 33290322 0,255,187
chr9 33290576 33290929 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 435 . 33290576 33290929 0,255,66
chr9 34048996 34049424 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 186 . 34048996 34049424 0,189,255
chr9 34126046 34126376 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 192 . 34126046 34126376 0,195,255
chr9 34328793 34329203 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 183 . 34328793 34329203 0,186,255
chr9 34611767 34612034 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 215 . 34611767 34612034 0,219,255
chr9 34665671 34665952 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 254 . 34665671 34665952 0,255,250
chr9 35071701 35072042 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 183 . 35071701 35072042 0,186,255
chr9 35096263 35096582 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 453 . 35096263 35096582 0,255,47
chr9 36191075 36191399 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 155 . 36191075 36191399 0,158,255
chr9 37080025 37080325 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 191 . 37080025 37080325 0,194,255
chr9 37120567 37121037 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 323 . 37120567 37121037 0,255,180
chr9 37486130 37486413 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 139 . 37486130 37486413 0,141,255
chr9 38227738 38227994 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 147 . 38227738 38227994 0,149,255
chr9 41954561 41955008 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 186 . 41954561 41955008 0,189,255
chr9 42019130 42019483 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 208 . 42019130 42019483 0,212,255
chr9 44402064 44402334 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 196 . 44402064 44402334 0,199,255
chr9 45169158 45169422 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 152 . 45169158 45169422 0,155,255
chr9 46687545 46687834 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 166 . 46687545 46687834 0,169,255
chr9 66458163 66458685 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 417 . 66458163 66458685 0,255,84
chr9 66553556 66553834 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 239 . 66553556 66553834 0,243,255
chr9 69065588 69065887 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 170 . 69065588 69065887 0,173,255
chr9 69261809 69262509 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 237 . 69261809 69262509 0,241,255
chr9 70489447 70490080 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 273 . 70489447 70490080 0,255,231
chr9 70856932 70857285 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 207 . 70856932 70857285 0,211,255
chr9 86594670 86595050 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 286 . 86594670 86595050 0,255,218
chr9 93955658 93955979 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 189 . 93955658 93955979 0,192,255
chr9 95055479 95055878 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 195 . 95055479 95055878 0,198,255
chr9 95087734 95088148 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 246 . 95087734 95088148 0,250,255
chr9 97489053 97489385 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 326 . 97489053 97489385 0,255,177
chr9 98637924 98638239 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 303 . 98637924 98638239 0,255,200
chr9 100684516 100684778 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 230 . 100684516 100684778 0,234,255
chr9 102669081 102669337 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 175 . 102669081 102669337 0,178,255
chr9 104295694 104295986 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 223 . 104295694 104295986 0,227,255
chr9 106856360 106856747 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 261 . 106856360 106856747 0,255,243
chr9 107510137 107510678 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 143 . 107510137 107510678 0,145,255
chr9 112778479 112778737 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 208 . 112778479 112778737 0,212,255
chr9 114557430 114557726 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 195 . 114557430 114557726 0,198,255
chr9 114908680 114909056 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 225 . 114908680 114909056 0,229,255
chr9 116037983 116038368 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 193 . 116037983 116038368 0,196,255
chr9 117268075 117268362 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 177 . 117268075 117268362 0,180,255
chr9 117350150 117350509 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 189 . 117350150 117350509 0,192,255
chr9 118012576 118012850 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 137 . 118012576 118012850 0,139,255
chr9 125027318 125027603 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 142 . 125027318 125027603 0,144,255
chr9 127630926 127631319 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 200 . 127630926 127631319 0,204,255
chr9 127951705 127951981 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 188 . 127951705 127951981 0,191,255
chr9 128469183 128469493 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 212 . 128469183 128469493 0,216,255
chr9 129567366 129567727 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 218 . 129567366 129567727 0,222,255
chr9 130213199 130213529 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 250 . 130213199 130213529 0,255,255
chr9 130477516 130477849 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 141 . 130477516 130477849 0,143,255
chr9 130565527 130565839 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 207 . 130565527 130565839 0,211,255
chr9 130829836 130830163 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 353 . 130829836 130830163 0,255,149
chr9 131398048 131398309 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 165 . 131398048 131398309 0,168,255
chr9 131419043 131419475 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 328 . 131419043 131419475 0,255,175
chr9 131446384 131446640 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 132 . 131446384 131446640 0,134,255
chr9 131644584 131644979 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 182 . 131644584 131644979 0,185,255
chr9 131710155 131710441 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 131 . 131710155 131710441 0,133,255
chr9 131902650 131902915 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 202 . 131902650 131902915 0,206,255
chr9 132176226 132176593 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 305 . 132176226 132176593 0,255,198
chr9 132245464 132245885 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 168 . 132245464 132245885 0,171,255
chr9 132388515 132388786 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 184 . 132388515 132388786 0,187,255
chr9 135230000 135230314 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 183 . 135230000 135230314 0,186,255
chr9 135545451 135545801 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 243 . 135545451 135545801 0,247,255
chr9 135753841 135754120 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 215 . 135753841 135754120 0,219,255
chr9 136215140 136215515 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 265 . 136215140 136215515 0,255,239
chr9 137029690 137029968 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 313 . 137029690 137029968 0,255,190
chr9 139305183 139305655 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 171 . 139305183 139305655 0,174,255
chr9 139685857 139686146 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 237 . 139685857 139686146 0,241,255
chr9 139796375 139796735 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 229 . 139796375 139796735 0,233,255
chr9 139980784 139981065 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 140 . 139980784 139981065 0,142,255
chr9 140512894 140513192 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 172 . 140512894 140513192 0,175,255
chrUn_gl000220 97136 97458 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 312 . 97136 97458 0,255,191
chrX 67718469 67718872 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 273 . 67718469 67718872 0,255,231
chrX 71496517 71496901 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 223 . 71496517 71496901 0,227,255
chrX 73833976 73834290 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 230 . 73833976 73834290 0,234,255
chrX 75393034 75393348 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 204 . 75393034 75393348 0,208,255
chrX 100646182 100646483 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 180 . 100646182 100646483 0,183,255
chrX 115004509 115005138 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 633 . 115004509 115005138 135,255,0
chrX 118602584 118602866 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 180 . 118602584 118602866 0,183,255
chrX 135962349 135962709 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 178 . 135962349 135962709 0,181,255
chrX 153236890 153237229 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 210 . 153236890 153237229 0,214,255
chrX 153626793 153627131 ID=SRX2254516;Name=H3K27ac%20(@%20BHY);Title=GSM2356642:%20H3K27ac-BHY%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Others;
source_name=Cancer%20cell%20line;tumor%20type=Head%20and%20neck%20squamous%20cell%20carcinomas;cell%20line=BHY;antibody=H3K27ac,%20Abcam,%20ab4729;treatment=NA; 192 . 153626793 153627131 0,195,255